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ABSTRACT 
Major depression with psychotic features (psychotic depression, PD) is a severe 
mental disorder characterized by depression and psychotic symptoms. Despite grave 
symptoms and high mortality, PD has remained under-researched. Furthermore, the 
majority of research has focused on the acute phase of the illness or included only a 
short follow-up. Few studies have focused on the risk factors or long-term outcomes 
of PD. 
In this thesis, the aim was to examine the risk factors, clinical characteristics and 
outcomes of PD. Firstly, a systematic review and meta-analysis were performed to 
analyze existing literature. Secondly, an original study in the Northern Finland Birth 
Cohort 1966 (NFBC 1966) was conducted. The NFBC 1966 is a naturalistic and 
prospective birth cohort study that includes 12058 subjects who had an estimated 
date of birth in 1966. The participants have been followed since mid-pregnancy for 
over 50 years. Data about study subjects were acquired from several different sources 
including national registers, clinical measurements and questionnaires. PD (n=55 in 
Study III; n=58 in Studies II and IV) was compared to other severe mental disorders 
and, regarding risk factors, to healthy controls (HC).  
Both in the meta-analysis and the study in the NFBC 1966, PD was found to 
have a worse clinical picture and prognosis than non-psychotic depression, 
comparable to psychotic bipolar disorder but better than in schizophrenia. The 
majority of PD patients were females. In the NFBC 1966, only a few significant risk 
factors for PD were found. These included mental illness in the family and low 
school sports grade in adolescence. The original study showed that, also in the long 
term, PD patients have negative outcomes such as impaired functioning and 
recurrent hospitalizations. Furthermore, male gender predicted worse outcomes. 
Psychiatric comorbidity was especially common in PD in the NFBC 1966 and 
associated with poor outcomes.  
To conclude, PD has similar outcomes than psychotic bipolar disorder and 
should be treated accordingly with a proper long-term focus. Due to a lack of 
research, more prospective studies with a long follow-up are urgently needed. 
KEYWORDS: Psychotic depression, risk factors, outcome, symptoms, gender, 
prospective  
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TIIVISTELMÄ 
Psykoottinen masennus tarkoittaa vakavaa masennusta, jonka yhteydessä ilmenee 
myös psykoottisia oireita kuten harhaluuloja tai hallusinaatioita. Siitä huolimatta, 
että psykoottiseen masennukseen liittyy vaikea oirekuva ja korkea kuolleisuus, sitä 
on tutkittu vain vähän. Suuri osa tutkimuksesta on myös keskittynyt sairauden 
akuuttivaiheeseen tai sisältänyt vain lyhyen seuranta-ajan eikä riskitekijöistä tai 
pitkän aikavälin ennusteesta ole kovin merkittävästi tietoa.  
Tämän väitöskirjatyön tavoitteena oli selvittää psykoottisen masennuksen 
riskitekijöitä, kliinisiä ominaispiirteitä ja ennustetta. Ensiksi tehtiin systemaattinen 
kirjallisuuskatsaus sekä meta-analyysi. Tämän jälkeen suoritettiin alkuperäis-
tutkimus, jonka aineistona oli Pohjois-Suomen syntymäkohortti 1966. Kohortin 
jäseniä on seurattu raskausajasta asti yli 50 vuoden ajan. Tutkimusaineisto kerättiin 
kansallisista rekistereistä, kliinisistä mittauksista ja kohortissa kerätyistä kysely-
lomakkeista. Psykoottista masennusta (n=55 osatyössä III; N=58 osatöissä II ja IV) 
verrattiin muihin vakaviin mielenterveyden häiriöihin. Lisäksi riskitekijöiden osalta 
käytettiin vertailuryhmänä myös terveitä verrokkeja.  
Sekä meta-analyysin että alkuperäistutkimuksen tuloksena oli, että psykoottisen 
masennuksen kliininen kuva ja ennuste ovat vaikeampia kuin ei-psykoottisessa 
masennuksessa, vastaavia kuin psykoottisessa kaksisuuntaisessa mielialahäiriössä ja 
parempia kuin skitsofreniassa. Enemmistö psykoottista masennusta sairastavista oli 
naisia. Pohjois-Suomen kohortissa vanhempien mielenterveysongelmat ja matala 
liikunnan kouluarvosana murrosiässä lisäsivät psykoottisen masennuksen riskiä. 
Alkuperäistutkimus osoitti sen, että psykoottiseen masennukseen liittyy heikko 
pitkäaikaisennuste. Psykiatrinen oheissairastavuus oli psykoottisessa masennuk-
sessa yleistä ja se ennusti vaikeampaa sairaudenkulkua, kuten myös miessukupuoli.  
Pitkällä aikavälillä psykoottiseen masennukseen liittyy toimintakyvyn lasku ja 
toistuvia sairaalahoitoja, jotka ovat vastaavia kuin psykoottisessa kaksisuuntaisessa 
mielialahäiriössä. Tämän vuoksi hoidon tulee olla pitkäjänteistä. Lisää prospek-
tiivisia seurantatutkimuksia psykoottisesta masennuksesta tarvitaan. 
AVAINSANAT: Psykoottinen masennus, riskitekijät, ennuste, oireet, sukupuoli, 
prospektiivinen  
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1 Introduction 
In 2012 Rebecca Lawrence, a practicing doctor from Scotland, wrote in the BMJ 
(Lawrence et al. 2012) about her history with mental illness: “Quite suddenly my life 
fell apart. I don’t remember feeling depressed, but I became terrified of everything, 
afraid to eat, and convinced the baby would die… What was my diagnosis? How to 
classify the feelings of fear, terrible fatigue, anxiety, and blackness? Depression was 
what I was told, but I formed an unshakeable conviction that everyone thought I had 
a personality disorder… When I read a textbook description of psychotic depression, 
my diagnosis, I can’t marry it with how I feel. I do feel low, but also agitated and 
frightened, and simply very ill.” 
Psychotic Depression (PD hereafter) is a severe and under-researched disorder 
characterized by the combination of depression and psychosis. The illness has been 
associated with specific clinical and biological findings. Therefore, it has been 
argued that PD should be considered a distinct illness (Schatzberg & Rothschild 
1992). Recommended and evidence-based treatments of PD include either 
combination therapy with an antidepressant and an antipsychotic medication (Flint 
et al. 2019) or electroconvulsive therapy (van Diermen et al. 2018). However, only 
a small number of studies have been conducted on the treatment of PD. Because PD 
sits in the middle of psychotic and affective disorders, it has been difficult for the 
science of psychiatry to find a stance on it. 
Kraepelin divided mental illness into two main categories in 1899 in his 
influential textbook of psychiatry (Kraepelin 1899). Dementia Praecox was a 
deteriorating continuous illness mostly affecting intellectual functioning while 
manic-depressive illness had an episodic course and affected mostly mood (Falkai 
et al. 2015). Psychiatry in the 20th and 21st centuries has been heavily influenced by 
this categorization and the paradigm shift away from the psychoanalytic tradition 
has sometimes been referred to as the “neo-Kraepelinian revolution” (Compton & 
Guze 1995). The abovementioned categories are still found in current diagnostic 
classifications renamed as schizophrenia (SZ) and bipolar disorder (BD), even 
though the validity of this dichotomy has often been criticized (Craddock & Owen 
2010). These disorders have also been targets of a thorough investigation while other 
Introduction 
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clinical presentations such as PD have remained under-researched (Crebbin et al. 
2008).  
Despite the multi-categorical nature of the prevailing diagnostic classifications, 
psychotic illness is currently understood differently. Psychotic symptoms are 
reasoned to appear on a continuum from mild and transient to severe and 
deteriorating, while also presenting themselves with almost all other symptom 
clusters across the diagnostic spectrum (Kelleher & Cannon 2016). Psychotic 
symptoms are conceptualized dimensionally, and schizophrenia is considered to 
include the 30% of people with the most severe symptoms (Guloksuz & Van Os 
2018). Schizophrenia has also been the main focus of research perhaps hiding the 
large variation of psychotic phenomena. Psychotic depression is an example of these 
other symptom clusters that have been largely ignored in the scientific literature. 
Almost as if they did not even exist (van Os 2016). 
It is important to remember that already Kraepelin believed a complete 
categorization of mental illness will prove impossible but still thought that clinical 
work needed diagnostic grouping (Kendler & Jablensky 2011). While research is 
revealing the dimensional nature of psychiatric illness and pragmatic categories are 
needed in the clinic, combining dimensional and categorical models may be a 
beneficial way forward (Chamberlain et al. 2018). 
Regardless of any debates concerning diagnostic systems, patients with 
depression and psychotic symptoms will continue to be a clinical reality. This study 
is an effort to increase knowledge about this disorder, of which very little is known 
about. This thesis includes a systematic review and meta-analysis of epidemiology 
and a naturalistic birth cohort study in the Northern Finland Birth Cohort 1966. 
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2 Review of the Literature 
2.1 Characteristics of Psychotic Depression  
2.1.1 Diagnosis of Psychotic Depression 
The diagnosis of PD (major depressive disorder with psychotic features or psychotic 
depression) and it’s nosological status have been debated for decades (Schatzberg & 
Rothschild 1992). Primary controversy has been about whether PD should be 
handled as a separate psychotic illness or as simply one type of severe depression. A 
vast amount of research has been published showing differences between PD and 
non-psychotic depression (NPD) to try to confirm that PD is a distinct illness and 
that it should be categorized as such (Rotschild 2013). 
Currently, PD is defined slightly differently in the 10th version of the 
International Classification of Diseases (ICD-10) and the most recent version of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5). In Finland, the 
ICD-10 system is currently in use. ICD-10 diagnostic criteria (Table 1; World Health 
Organisation 1992) dictate that a patient must exhibit symptoms of severe depression 
accompanied by psychotic symptoms and the psychotic symptoms are also required 
to be other than typically schizophrenic. DSM-5 (American Psychiatric Association 
2013) separates affective and psychotic symptom dimensions in the way that PD 
may be diagnosed in a person with mild or moderate depressive symptoms.  
In clinical settings, the diagnosis of PD is often missed. Rothschild et al. 
conducted a study (2008) in 4 academic medical centers to examine how accurate 
the diagnosis of PD is in naturalistic environments. They found that in 27% of 
diagnostic evaluations the diagnosis of PD was missed. Failure to correctly diagnose 
PD was especially common in emergency room settings (39%) and it was also more 
common among attending psychiatrists (34%) than among psychiatry residents 
(10%). In this study, it was the psychotic symptoms that were missed and not the 
mood disorder. The authors note that the actual symptoms, such as guilt, were often 
in these cases noticed but they were not interpreted to be psychotic. This underlines 
the difficulty in separating psychotic and non-psychotic feelings of guilt. 
Review of the Literature 
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Table 1.  Diagnostic criteria for PD according to ICD-10 (The ICD-10 Classification of Mental and 
Behavioural disorders – Diagnostic criteria for research). 
 
Different measurement scales are routinely used to assess psychiatric disorders. The 
Psychotic Depression Assessment scale (PDAS) is the only empirically validated 
measurement scale for PD (Østergaard et al. 2015). The scale has been developed in 
2014 and it combines six items of the Hamilton Melancholia Subscale with relevant 
items from the Brief Psychiatric Rating Scale (Østergaard et al. 2014a). PDAS can 
be used to screen for PD among patients with depression (Park et al. 2014a) and in 
the measurement of response to treatment (Østergaard et al. 2014a).  
Miika Nietola 
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2.1.2 Symptoms of Psychotic Depression 
The symptoms of PD are in many ways like those of severe NPD, such as lowered 
mood, anhedonia, loss of appetite and problems with concentration, but there are 
also certain important separating differences. First, the depressive symptoms must 
be accompanied by psychotic symptoms: either hallucinations, delusions or 
psychomotor retardation (World Health Organization 1992). Characteristic 
psychotic symptoms in PD are overwhelming feelings of guilt during which the 
patient may, for instance, have delusions about having committed a crime or being 
responsible for a pending disaster. Secondly, patients with PD often exhibit a 
different clinical picture concerning symptom severity than patients with NPD. 
According to literature, the depressive symptoms in PD are more difficult than 
in severe NPD both in younger samples (Rush et al. 2006; Zaninotto et al. 2013) and 
in older age (Gournellis et al. 2001). Therefore, psychotic symptoms in severe 
depression indicate that also the depressive symptomatology is more likely to be 
harsh. In a large European multicenter study (Dold et al. 2019) PD patients were also 
more likely to have melancholic characteristics than patients with severe NPD, in 
addition to having more severe depressive symptoms. 
Depressive symptoms of PD patients have also been compared to depressive 
symptoms in SZ. The results of these studies have been conflicting (Craig et al. 2000; 
Hill et al. 2004) and currently, it is not known whether there is a difference between 
depressive symptom severity in PD and SZ. It is known that depression is common 
at different stages of SZ (Upthegrove et al. 2017) and this causes a challenge to 
diagnostic categorization and clinical practice. However, psychotic symptoms in SZ 
are more severe than in PD (Taiminen et al. 2000; Jäger et al. 2005) and this applies 
to both positive (Craig et al. 2000; Hill et al. 2004) and negative (Craig et al. 2000; 
Owoeye et al. 2013) symptoms. 
The comparison of PD and psychotic bipolar disorder (PBD) is also of great 
interest. It seems that PD patients have more negative symptoms but at the same time 
exhibit fewer positive symptoms than patients with PBD (Craig et al. 2000; 
Dell’Osso et al. 2002; Owoeye et al. 2013). The results concerning depressive 
symptoms have been more mixed (Benazzi 1999; Dell’Osso et al. 2002). 
2.1.3 Diagnostic instability  
The validity of psychiatric diagnosis is in part evaluated by how stable the diagnosis 
is over a long period. Many factors are affecting this level of consistency during 
recurring diagnostic assessments such as the changes in the symptom presentation 
over time, the diagnostic process and the reliability and validity of diagnostic 
classification (Nietola et al. 2017). Descriptive diagnoses need to reach a certain 
level of stability to be clinically useful.  
Review of the Literature 
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There are two central aspects to the question of diagnostic stability in PD. Firstly, 
it is important to know how often PD diagnosis converts to other diagnoses such as 
schizophrenia or bipolar disorder. Secondly, psychotic symptoms may accompany 
depression only once or recur during every depressive episode. The latter affects our 
understanding of the diagnostic stability of PD even though there is no conversion 
away from the diagnosis of depression. 
The diagnostic stability in PD has been criticized to be low and, due to this, it 
has been suggested that the diagnosis of PD should be regarded as provisional 
(Ruggero et al 2011). However, there has been much variation between studies and 
different studies have shown diagnostic consistency (no change in diagnosis) from 
24% (Forrester et al. 2001) to 100% (Schimmelmann et al. 2005). There are many 
components in the studies that may have affected this such as length of the follow-
up, diagnostic tools that were used and the age of the sample. Also, study design 
including only first-episode cases as opposed to other samples is likely to influence 
diagnostic stability since first-episode diagnoses may often change while non-first-
episode samples consist of patients who are more ill (Heslin & Young 2018). In the 
studies with the longest duration of follow-up, approximately 45% of patients 
diagnosed with PD at baseline had the same diagnosis ten years afterward (Ruggero 
et al. 2011; Heslin et al. 2015). Both of these studies included young adults with the 
median age at baseline being roughly thirty years. 
The results of a large systematic review and meta-analysis conducted at The 
University of California supported the diagnostic consistency of PD over longer 
periods (Nelson et al. 2018). The researchers compared patients with an index 
episode of PD to those with NPD. They found PD patients to have nearly a ten-fold 
risk of having had prior or subsequent episodes of PD compared to patients with 
NPD. They also compared the risk of the patient having had all depressive episodes 
accompanied by psychotic symptoms and found that patients with PD had over seven 
times bigger risk for this to have happened. 
The age of the sample is especially important in PD when analyzing diagnostic 
stability. Depression of old age may be a prodromal phase of dementia (Singh-
Manoux et al. 2017) and PD may be even more common in old age than among 
younger population (Kivelä & Pahkala 1989; Perälä et al. 2007). Also, younger onset 
age of PD is a probable risk factor for conversion to BD (Østergaard et al. 2014b) 
and it is likely to predict conversion from unipolar depression to SZ (Musliner et al. 
2017). Therefore, it seems that the relationship between the age of the sample and 
diagnostic stability is complex and needs to be taken into account when planning and 
interpreting all studies conducted on PD. 
It is also important to remember that PD is not the only psychiatric disorder 
undergoing debates about diagnostic validity due to relatively low diagnostic 
stability, causing vague boundaries between disorders. NPD and BD have also 
Miika Nietola 
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shown quite low rates, like PD, in diagnostic consistency (Baca-Garcia et al. 2007). 
Although there are many limitations to the current categorical diagnostic system, and 
therefore it may be legitimately criticized, the lack of research concerning PD cannot 
be justified based on a uniquely low diagnostic consistency. 
However different study designs may produce different results if the diagnostic 
change is not considered. Different diagnostic shifts do not only affect the validity 
of the diagnostic group of PD but potentially lower the validity of comparison groups 
that also may drift to other diagnoses, including PD (Figure 1). 
 
Figure 1. Illustration of potential diagnostic changes during follow-up 
studies. 
2.1.4 Onset age 
Studies on the onset age (first episode of PD) show a great variation in results. For 
example, in samples with first-episode psychosis the youngest mean onset age has 
been 25.2 years (Hill et al. 2004) and the oldest 51.5 years (Nakamura et al. 2015). 
In other samples, the variation has been even more significant. In two studies from 
the USA, Gaudiano et al. (2009) reported a mean onset age of 20.7 years while in 
the study by Meyers et al. (1999) it was 67.5 years. These major differences naturally 
reflect on the other hand methodological differences but also give information about 
the different courses of illness in PD: the first episode of PD may appear in early 
adulthood or at a significantly older age. Different age groups have been analyzed in 
different studies and this selection of the sample also affects the differences between 
the onset age in PD compared to other disorders. Variation in onset age, in addition 
to diagnostic instability, causes challenges to the research of PD. No previous meta-
analyses have analyzed the onset age in PD. 
Review of the Literature 
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2.1.5 Cognitive changes in Psychotic Depression 
Cognitive symptoms have been long recognized to exist in different psychotic 
disorders and their more specific characteristics and possible differences have been 
examined. PD has been associated with significant cognitive disturbances. A review 
and meta-analysis from 2004 discovered cognitive domains where there was a 
decrease in performance and these changes were more prominent among PD patients 
than in NPD (Fleming et al. 2004). Most affected cognitive domains were verbal 
memory, executive functioning and psychomotor speed. However, the authors 
mention several limitations especially due to the lack of relevant studies. 
Another meta-analysis found significant cognitive impairments in affective 
psychoses as a group and did not report a significant difference between PD and BD 
(Bora et al. 2010). The interpretation of these results also had a limitation of a 
relatively small amount of studies about PD. 
Most recent evidence is examined in the meta-analysis by Zaninotto et al. (2015). 
They analyzed studies that compared PD to NPD. Significantly more cognitive 
deficits were found in patients with PD and the largest impairments were found in 
verbal learning, visual learning and processing speed. The effect sizes were larger in 
unmedicated patients, which implicates a potential benefit of pharmacological 
treatment on cognition in PD. Cognitive deficits appeared to be qualitatively similar 
to those reported in SZ and worse than those in BD (Zaninotto et al 2015). 
2.1.6 Biological findings 
2.1.6.1 Neuroanatomy and neurobiology 
There is a clear lack of studies focusing on the neuroanatomy of PD and the results 
so far have been mostly heterogeneous. Reduced volume of the posterior subgenual 
cingulate cortex has previously been reported in PD (Coryell et al. 2005). Structural 
changes were also analyzed in a newer study that compared PD patients to HC 
(Bijanki et al. 2014). The results showed a significant reduction of hippocampal 
volume bilaterally in PD, perhaps a consequence of hypercortisolism. Another 
finding in the study was that the subcallosal region of the anterior cingulate cortex 
(scACC) was smaller among those PD patients with a family history of depression, 
which may indicate genetic vulnerability. Also, according to a review by Busatto 
(2013), most studies have not found neuroanatomical differences between PD and 
NPD, which can be seen to posit PD close to NPD in regard to these biological 
findings. However, some studies show that PD may be associated with additional 
structural and functional brain abnormalities in comparison to NPD, while these 
changes are still not as significant as in SZ (Busatto 2013).  
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A more recent study using resting-state functional magnetic resonance imaging 
(fMRI) investigated the functional connectivity between the hypothalamus and the 
subgenual cortex and found a clear reduction in the PD group compared to HC 
(Sudheimer et al. 2015). The authors discuss that decreased connectivity may be 
causing often observed HPA (hypothalamus-pituitary-adrenal) axis functional 
abnormalities, such as cortisol dysregulation, or be the consequence of these 
changes. Another study utilizing resting-state fMRI compared remitted PD patients 
with HC and found specific changes in the default mode network (DMN) (Neufeld 
et al. 2018). 
Other interesting findings have also been made. Sapru et al. (1989) analyzed 
serum dopamine-beta-hydroxylase (DBH) levels and discovered decreased activity 
in the PD group compared to HC. Patients with NPD, manic symptoms or SZ did not 
show this deviation. Abnormalities in the sleep patterns of PD patients have also 
been detected. Thase et al. (1986) found decreased rapid eye movement (REM) sleep 
in PD patients compared to NPD. 
2.1.6.2 Hypothalamus-pituitary-adrenal (HPA) axis 
The functioning of the hypothalamus-pituitary-adrenal (HPA) axis and the cortisol 
hormone have been studied in many psychiatric disorders since they are essential in 
the regulation of stress. Especially the stress responses in a variety of psychiatric 
disorders have been found to exhibit physiological deviations from HC (Zorn et al. 
2017). These changes are prominent in depression (Viinamäki et al. 2012). 
Disturbances of the HPA axis have been studied for decades and these abnormalities 
seem to be more common in PD than in NPD or among HC (Nelson & Davis 1997; 
Belanoff et al. 2001). These documented aberrations include elevated cortisol levels 
both in the afternoon and in the evening. In addition, a blunted response to 
fludrocortisone and non-suppression in the dexamethasone-test have been found 
(Keller et al. 2017). These changes are likely to have implications for somatic health 
and may partly explain the increased mortality reported in PD (Coryell et al. 2008). 
Along with direct physiological influence, hypercortisolism is likely to have a 
significant negative effect not only on the cognitive functioning of PD patients but 
on HC as well, and cortisol levels seem to correlate with cognitive functioning 
(Belanoff et al. 2001).  
There has also been an effort to localize potential genetic predispositions to 
cortisol dysfunction in PD and researchers found that variation in the glucocorticoid 
receptor gene explains a significant amount of differences in cortisol levels 
(Schatzberg et al. 2014). A recent interesting and high-quality study conducted at 
Stanford University aimed to investigate in combination the roles of HPA axis 
activity, clinical symptoms, HPA genetic variation and cognition in HC and patients 
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with PD and NPD (Keller et al. 2017). High cortisol levels were associated with 
lower cognitive functioning and PD patients had both lower cognitive functioning 
and higher cortisol levels than other groups. The study also found that genetic 
variation in glucocorticoid and mineralocorticoid receptor genes predicted specific 
cognitive functions and paralleled the estimated density of those receptors in the 
areas of the brain responsible for those cognitive functions.  
Studies analyzing the HPA-axis function in SZ have been heterogeneous 
indicating the possibility of both hypo- and hyperfunction (Bradley & Dinan 2010). 
A recent study compared PD and SZ regarding HPA axis function and cognition and 
their results showed higher evening cortisol levels in PD, while there was no 
significant difference in cognitive functioning (Cherian et al. 2019). However, as 
discussed in the article, these results may be affected by the SZ group consisting of 
less acutely ill patients, and cortisol functioning is likely to be different at different 
phases of the illness in both SZ and PD. 
2.2 Treatment of Psychotic Depression 
2.2.1 Standard pharmacological treatments 
The effects of different pharmacological agents in the treatment of PD are heavily 
understudied (Wijkstra et al. 2015). A meta-analysis by Farahani & Correll (2012) 
analyzed 8 randomized studies with placebo-control that were conducted in the acute 
phase of the illness. They found that combination treatment with both an antidepressant 
and an antipsychotic was more effective than monotherapy with either medication 
alone. Cochrane Database review from 2015 (Wijkstra et al. 2015) reached similar 
conclusions although they alerted the reader of considerable risk of bias and a low 
quantity of studies that lowers the reliability of results. The Finnish guidelines for the 
treatment of depression recommend combination treatment with an antidepressant and 
an antipsychotic medication in PD (Depression: Current Care Guidelines, 2020). 
Until recently, there has been little evidence to support any particular method of 
continuation therapy after remission. Since antidepressants have for long been 
recognized to be effective in preventing relapses of depression, a major question has 
been about how long antipsychotic medication should be used in PD. A recent study 
(Flint et al. 2019) examined the effect of discontinuing the antipsychotic medication 
after remission on the relapse rate during a 36-week follow-up. Patients were treated 
to remission with sertraline plus olanzapine. After 36 weeks, 20.3% of patients still 
using olanzapine had experienced a relapse compared to 54.8% of those who had 
switched to placebo. There was a significant difference (p<0.001) favoring the 
usefulness of continuing antipsychotic medication after remission. However, 
olanzapine was associated with adverse effects such as weight gain.  
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2.2.2 Electroconvulsive therapy 
Electroconvulsive therapy (ECT) has been used for nearly a hundred years and 
remains to be considered the most effective treatment for mood disorders, while it is 
underused and there is great geographical variation in ECT availability (Sackeim 
2017). In 2002, ECT was estimated to be used for 1 million patients globally 
(Abrams 2002). A meta-analysis published in the British Journal of Psychiatry (van 
Diermen et al. 2018) confirmed that ECT is especially effective with patients 
suffering from PD. Efficacy of ECT has been confirmed in studies that included a 
sham ECT as a control group (Buchan et al. 1992). ECT is recommended for the 
treatment of PD in the Finnish depression guidelines (Depression: Current Care 
Guidelines, 2020). 
Cognitive side-effects have been a significant concern when using ECT. It is 
known that ECT causes brief confusion immediately after the procedure, transient 
anterograde amnesia and a varying amount of retrograde amnesia (Kellner & Farber 
2016) but most cognitive side effects are limited to first three days and ECT may 
also improve cognitive functioning in depressed patients (Semkovska & 
McLoughlin 2010). Technical advances concerning the administration of the 
treatment are also decreasing the effect of these side effects (Sackeim 2017). ECT is 
associated with an extremely low mortality rate (Tørring et al. 2017).  
A high relapse rate has also been limiting the use of ECT previously (Sackeim 
2017). A meta-analysis examining relapse rates post-ECT discovered that despite 
continuation pharmacotherapy following ECT, approximately half of the patients are 
likely to relapse within a year and most of these within 6 months. Also, without 
continuation medication, the relapse rates were as high as 80% (Jelovac et al. 2013).  
The mechanism of action causing the beneficial effects of ECT is currently 
unknown, but several changes have been found to accompany ECT treatment 
involving, for example, functional connectivity, gene expression and immune system 
(Singh & Kar 2017). According to a recent meta-analysis, it seems that ECT 
increases the size of the hippocampal regions and the amygdala (Takamiya et al. 
2018) but hippocampal growth is not a marker for clinical outcome (Oltedal et al. 
2018).  
There is a shortage of studies on the continuation and maintenance ECT 
treatment of PD. When combined with nortriptyline, continuation and maintenance 
ECT was more effective than medication alone in preventing relapse in old age PD 
over a 2-year follow-up (Navarro et al. 2008). Additionally, in NPD samples, 
continuation ECT treatment has shown promise when combined with medication 
(Gagné et al. 2000; Kellner et al. 2016). However, in one study conducted on NPD 
patients, continuation ECT was not more effective than the combination of 
nortriptyline and lithium in preventing relapse (Kellner et al. 2006). 
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2.2.3 Other treatments 
Psychotherapeutic treatments of PD have not been studied almost at all. Preliminary 
results have shown that PD patients may benefit from acceptance-based behavioural 
treatment combined with pharmacotherapy and the treatment is likely to be 
acceptable by patients (Gaudiano et al. 2013). As noted in the study mentioned 
above, cognitive behavioural therapy has not been previously studied in PD samples 
but some studies have included PD patients and shown encouraging results. 
However, subclinical psychotic symptoms have been shown to predict worse 
psychotherapy outcomes in depression (Wigman et al. 2014). Also, in patients with 
depression and post-traumatic stress disorder, the presence of psychotic symptoms 
predicted worse outcomes (Gottlieb et al. 2011). 
HPA axis disturbance and hypercortisolism have been found to be common in 
PD and to associate with cognitive disturbances. These results have added 
motivation to find ways to safely and effectively pharmacologically regulate cortisol 
levels in PD. A glucocorticoid receptor antagonist mifepristone has been studied the 
most and has shown promise in the treatment of PD but is not currently in standard 
clinical use (Block et al. 2018). There are also some case reports favoring the use of 
ketoconazole in PD (Kling et al. 2009). Unfortunately, no studies have investigated 
the effectiveness of ketoconazole in PD, despite the fact, that ketoconazole seems to 
be most effective in NPD when the patient presents with hypercortisolemia 
(Lombardo et al. 2009). 
2.3 Epidemiology of Psychotic Depression  
2.3.1 Prevalence, incidence and proportion of psychosis in 
depression 
A Finnish nationally representative study with a sample of people over 30 years of 
age showed a lifetime prevalence of 0.35% in PD (Perälä et al. 2007). Other studies 
have found higher prevalence rates. In an American community sample (the 
Epidemiological Catchment Area study), the lifetime prevalence was 0.6% (Johnson 
et al. 1991) and in a telephone survey conducted in several European countries, there 
was a 0.5% point prevalence in PD (Ohayon & Schatzberg 2002). In the latter study, 
there was also variation between different countries and social groups.  
The annual incidence of PD has been studied in a few studies. Reay et al. (2010) 
found an annual incidence of 6.0 per 100 000 persons in a sample of patients 16 years 
old or older. In the Cavan-Monaghan First Episode Study conducted in Ireland the 
annual incidence was similar (6.4 per 100 000) (Baldwin et al. 2005). In the UK, 
Farquhar et al (2007) reported a lower annual incidence of 3.0 per 100 000 in 1995. 
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A study in Northern Finland reported a significant growth in cumulative incidence 
until age 27 years from 0.02% in 1966 to 0.27% in 1986 (Filatova et al. 2016). 
Psychotic symptoms are present in a minority of patients with depression. 
Currently, it is estimated that 11-25% of patients with depression exhibit psychotic 
symptoms (Coryell et al. 1984a; Johnson et al. 1991; Ohayon & Schatzberg 2002; 
Gaudiano et al. 2016; Dold et al. 2019). This proportion is likely to be higher in 
inpatient than outpatient samples (Rothschild 2013). 
The lifetime prevalence rate of major depressive disorder is estimated to be 15-
18% (Malhi & Mann 2018), and, therefore, higher lifetime prevalence rates of PD 
should be found if psychotic symptoms are genuinely as common in depression as 
described in previous studies. It is possible that PD is especially difficult to detect in 
epidemiological studies investigating the lifetime prevalence or the studies focusing 
on the prevalence of psychotic symptoms in depression may have had more ill 
patients leading to a biased sample. 
In a Finnish study, 26% of inpatients diagnosed with depression had psychotic 
symptoms, compared to 5% of secondary care outpatients and 1% of primary care 
patients (Vuorilehto et al. 2007). When investigating the prevalence of psychotic 
symptoms in depression, it is especially important to pay attention to the 
characteristics of the sample, since there is significant variation between different 
patient populations. 
2.3.2 Risk factors and sociodemographic findings 
The risk factors of PD have not been studied as much as in other severe mental 
disorders and especially the early risk factors are mostly unknown with only one 
previous study analyzing risk factors since birth (Østergaard et al. 2013). This 
Danish study utilized extensive national registers to analyze a large PD sample 
(n=2183) but gestational age, birth weight and maternal or paternal age were not 
found to associate with an increased risk for PD. 
Childhood traumas are likely to be a risk factor for PD, but the results on the 
studies that have analyzed childhood traumatic events in PD have been slightly 
contradicting. In an outpatient study, childhood traumatic events were more 
common in PD than in NPD (Gaudiano & Zimmerman 2010), but this difference 
was not significant in an inpatient sample (Gaudiano et al. 2016).  This may be due 
to more severe cases of NPD in the inpatient sample. In the AESOP study, 
conducted in defined catchment areas in the UK, PD patients more often had 
experienced childhood adversity (Heslin et al. 2016b). In the same study, certain 
social factors were found to associate with PD. Unemployment, living alone, 
having few contacts with friends and having no close confidants were more 
common in patients with PD. 
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Østergaard et al. (2013) found in their study that those who had suffered the loss 
of a mother due to unnatural causes after the age of 15 had an elevated risk of PD. 
This effect was not significant if this event had taken place when the person was 
under 15 years old, possibly due to sample size. However, based on this study, it is 
likely that the loss of a relative, in general, is a risk factor for PD also, as it is for 
NPD. 
The educational background of PD patients has been looked at in quite many 
studies but there has been no specific observable educational profile. In some studies 
PD patients have had lower education than in PBD (Breslau & Meltzer 1988) and in 
NPD (Gaudiano et al. 2009). Johnson et al. (1991) found PD to be associated with a 
lower socioeconomic status than NPD. Most studies analyzing marital status in PD 
and comparing it to other disorders have found differences to be nonsignificant. Few 
studies reported significant differences. PD patients were found to be more often 
single than patients with NPD in an elderly sample (Baldwin 1995) and among 
inpatients (Gaudiano et al. 2016). 
Several studies have analyzed the ethnicity of patients diagnosed with PD. The 
most common finding has been that PD patients were more often non-Caucasian 
(Goldberg & Harrow 2005, Gaudiano et al. 2016). In a British study, minor physical 
anomalies were not more common in patients with PD but neurological soft signs 
were (Heslin et al. 2016b). 
2.3.2.1 Gender differences 
Very little research has been carried out to examine gender differences in PD (Park 
et al. 2015). However, studies indicate that the prevalence of PD among females is 
higher than among males comparably to NPD (Kessing et al. 2005; Østergaard et al. 
2013). Therefore, this finding of the different prevalence of PD between genders 
differs from SZ where the majority of affected persons are male (Perälä et al. 2007). 
Female PD patients have been reported to have more often disorganized 
(Deligiannidis et al. (2013), systematized and mood-incongruent psychotic 
symptoms in addition to increased fatigue and psychomotor agitation (Fennig et al. 
1993). Park et al. (2015) analyzed gender differences in a different sample where 
they included all patients with depression and psychotic symptoms into the PD 
group, including also patients with mild or moderate depression symptoms. Their 
inclusion criteria were, therefore, more in line with the current DSM-5 diagnostic 
criteria. The results of the study showed a higher prevalence of hallucinatory 
behavior among men after adjusting for the effects of marital status. Park et al. 
consider that the confounding effect of marital status in a previous study by 
Deligiannidis et al. (2013) may have explained the opposite results regarding gender 
difference. 
Miika Nietola 
 24
Current evidence suggests that male PD patients are at a higher risk of 
committing suicide than female patients (Leadholm et al. 2014). This finding is in 
line with other psychiatric illnesses, in which male gender is recognized as a 
significant risk factor for suicide (Large et al. 2011). Several reasons for this gender 
difference have been suggested including the use of more violent methods and 
cultural factors such as reluctance towards help-seeking and maladaptive coping 
strategies caused by traditional masculinity (Möller-Leimkühler et al. 2003). 
Regarding comorbidity, male PD patients seem to have more often a comorbid 
alcohol use disorder (Fennig et al. 1993, Isometsä et al. 1994). Studies about the 
prevalence of comorbid anxiety symptoms have shown contradicting results (Fennig 
et al. 1993; Deligiannidis et al. (2013), possibly due to methodological differences 
discussed above. 
2.3.2.2 Family history of mental illness 
It is well known that parental mental illness confers a clearly increased risk of several 
mental disorders among offspring. The increased risk of mental disorders caused by 
parental mental illness is likely to be at least partly transdiagnostic in nature, so that 
for example also non-affective psychotic illness among parents increases the risk of 
affective psychotic illness among offspring, and the risk is cumulative in the way 
that 2 affected parents cause a greater risk than 1 affected parent (Dean et al. 2010).  
Mental illness in the family has been shown to be a risk factor for PD (Heslin et 
al 2016). Depression in the family has not been found to be more common in PD 
than in NPD (Park et al. 2014b) but maternal mental illness was more common in 
PD in a large Danish register-study (Østergaard et al. 2013). A family history of BD 
seems to be more common in PD than in nonpsychotic depression (Maj et al. 2007; 
Østergaard et al. 2013). These studies do not separate the genetic and environmental 
factors affecting this increased risk, but both likely have a significant role. 
According to clinical genetics studies, there is significant familial aggregation 
and heritability (39%) in PD (Domschke 2013). This heritability is partly shared with 
other severe mental illnesses such as schizoaffective disorder, schizophrenia and 
affective disorders.  
2.4 The outcome of Psychotic Depression 
2.4.1 Hospitalization 
Due to severe symptomatology, PD patients are often hospitalized during the course 
of their illness. Four different studies have analyzed the difference between PD and 
NPD in the amount of hospitalization. All these studies have investigated only 
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inpatients. A 15-year follow-up study in Germany found a significantly higher 
number of rehospitalizations in the PD group (n=2.8) than in NPD (n=1.3) (Jäger et 
al. 2005).  In a small Italian study PD was associated with a longer duration of current 
hospital stay (33.7 days in PD and 15.1 days in NPD) but with less previous 
hospitalizations (n=2.9 in PD and n=4.1 in NPD), although the latter difference was 
non-significant (Buoli et al. 2013). Further research is needed to clarify whether 
there are significant differences between PD and NPD.  
When comparing SZ and PD, during a ten-year follow-up in the AESOP study 
conducted in the UK, patients with PD had spent significantly fewer days (63.5) in 
the hospital than patients with SZ (107) (Heslin et al. 2016a). In this study, there was 
no significant difference in hospitalization rates between PBD and PD. 
Contradictingly, Jäger et al. (2005) did not find a significant difference in the 
frequency of rehospitalizations between PD (n=2.8) and SZ (n=2.9). In addition, no 
difference was detected in another study with first-episode psychosis patients 
conducted in England (Crebbin et al. 2008), although there was a rather large 
absolute difference in hospitalization days between PD and SZ during the follow-up 
(mean days: 124 in PD and 231 in SZ). PBD was not examined in these two latter 
studies. In light of these studies, SZ is likely associated with more hospitalization 
than PD. The potential differences between PD and PBD remain unclear. 
2.4.2 Symptomatic remission, relapse rate and functional 
outcome 
There are some mostly old studies addressing the symptomatic remission and relapse 
rate in PD. In one inpatient study with a mean follow-up period of 2.4 years, 
remission rates were very low and lower in PD (19% for depressive symptoms and 
35% for psychotic symptoms) than in NPD (29% for depressive symptoms) (Sands 
& Harrow 1994), while another study with a sample of over 65-year-olds showed no 
significant difference between these two (Baldwin 1988). The relapse rate during 48 
months follow-up in PD (46%) appears to be higher than in NPD (25%) when 
analyzing relapses based on hospital readmissions (Baldwin 1988). However, when 
out-patient relapses were added, there was no difference between PD and NPD (50% 
for both). 
Considering the fact, that PD has been estimated to be especially severe 
regarding symptoms and clinical course (Keller et al. 2007), studies focusing on the 
functional outcome have been somewhat inconclusive. When comparing to NPD, 
PD patients’ global outcome has been somewhat poorer (Gaudiano et al. 2009; Jäger 
et al. 2005) but there are also contradicting results (Coryell et al. 1986). Same 
heterogeneity of results applies for the occupational outcome, where some studies 
show worse occupational outcome for PD (work impairment:70.8%) than NPD 
Miika Nietola 
 26
(34.2%) (Coryell et al. 1984b), while some studies show no difference between these 
two (Rush et al. 2006).  
Global clinical outcome in PD appears to be better (Craig et al. 2000; Jäger et al. 
2005) and the relapse rate lower (Craig et al. 2000) than in schizophrenia. Also, 
occupational functioning is better in PD during follow-up (Coryell & Tsuang 1985; 
Jäger et al. 2005) and full recovery seems to be more common (Coryell & Tsuang 
1982). Compared to PBD, results on global clinical outcomes have been conflicting 
(Craig et al. 2000; Dell’Osso et al 2002), but the functional outcome in PD and PBD 
is likely to be similar (Kingston et al. 2018). Meanwhile, rehospitalization rates 
during a 24-month follow-up (31.4% for PD and 33.6% for PBD) (Craig et al. 2000) 
and functional recovery rates after a six-month follow-up (31.8% for PD and 32.6% 
for PBD) (Tohen et al. 2000) were similar in PD and PBD. Results on the 
occupational outcome also reflect comparable outcomes (Dell’Osso et al. 2002). 
2.4.3 Comorbidity 
According to an extensive Danish register-study, psychiatric comorbidity seems to 
be extensive throughout the spectrum of mental illness in the way that most 
psychiatric disorders cause an increased risk to most other psychiatric disorders, 
regardless of which of them occurs first (Plana-Ripoll et al. 2019). However, certain 
pairs of disorders carry a more significant risk of co-occurrence than others. 
PD has been associated with certain psychiatric disorders and also general 
medical illness. In the McLean-Harvard first-episode project 37.5% of PD patients 
had any comorbid Axis 1 disorder (excluding substance use disorders) (Tohen et al. 
2012). A large European multicenter study examined the prevalence of comorbid 
anxiety disorders in PD and found 13.6% to have any current anxiety disorder, out 
of which generalized anxiety disorder was the most common (8.4%) (Dold et al. 
2019). In an inpatient sample, Gaudiano et al. (2016) reported a much higher 
comorbidity of anxiety disorders (58.6%). When analyzing the lifetime prevalence 
of anxiety disorders in an outpatient sample, the same research group reported high 
prevalence rates for different anxiety disorders (8.3-56.7%) (Gaudiano et al. 2009). 
In this study, opposite to the study by Dold et al. (2019), the most infrequent disorder 
was generalized anxiety disorder. The most frequent was posttraumatic stress 
disorder. 
The prevalence of comorbid personality disorders in PD has been looked at in a 
few studies. Especially comorbid A cluster personality disorders have been found to 
be common (Serretti et al. 1999; Gaudiano et al. 2009). Previously, borderline 
personality disorder has not been shown to be more prevalent among PD patients. 
The differential diagnosis may also be sometimes difficult between PD and 
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borderline personality disorder, if the patient exhibits minor and transient or 
otherwise “false” psychotic symptoms (Gaudiano et al. 2009). 
Harmful use of psychoactive substances is a major comorbidity affecting the 
clinical course in different psychiatric illnesses. In PD the prevalence of comorbid 
substance use disorders is very high. Tohen et al. (2012) reported that a stunning 
89.3% of PD patients had either alcohol or drug abuse or dependence at the 
beginning of the study, and in the case of 62.5% of the patients, the substance of use 
was alcohol. In the inpatient sample by Gaudiano et al. (2016) 41.4% had a comorbid 
substance use disorder while in the outpatient sample this prevalence was 55.0%. 
General medical comorbidity has also been shown to be high in PD. In an 
inpatient sample, those diagnosed with PD had more medical comorbidities than 
patients with NPD (Gaudiano et al. 2016). High medical comorbidity may also 
predict diagnostic stability in PD. In a study by Tohen et al. (2012) 86.2% of patients 
who held their diagnosis of PD in a two-year follow-up had general medical 
comorbidity, while only 40.0% of those whose diagnosis had changed (p=0.002). 
2.4.4 Mortality and suicide 
The most influential study about mortality in PD was published in 2003 
(Vythilingam et al. 2003). The authors compared mortality rates in PD (61 patients, 
59% female) and NPD (59 patients, 64% female) over a follow-up period of 15 years. 
After age and medical comorbidity were controlled, PD patients had a twofold 
mortality rate in comparison to NPD. This increased mortality was not explained 
with more suicides either. General medical illness was the cause of death in most 
cases in the whole sample (30/34 in total). The patients also underwent a 
dexamethasone suppression test (DST) to examine for hypercortisolism. PD subjects 
more often had a positive test result indicating hypercortisolism, but this did not 
predict mortality autonomously, in spite of the well-known detrimental effects of 
hypercortisolism on physical health. In light of the results of the previous study, it is 
interesting that in a large nationally representative Finnish study of over 8000 
persons affective psychoses as a group were not associated with increased mortality 
(Suvisaari et al. 2013). More evidence for the increased mortality in PD brings the 
study by Murphy et al. (1983), which found very high mortality in a sample of old 
age PD patients. 
Different studies that have been carried out over the years have had conflicting 
results about whether PD is associated with more suicides than NPD, but a 
systematic review indicated that particularly in the acute phase of the illness PD 
patients are more likely to die of suicide (Zalpuri & Rothschild 2016). Also, another 
recent systematic review and meta-analysis found psychosis to be a risk factor for 
suicide in major depression during the acute phase but also over the lifetime 
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(Gournellis et al. 2018a). In Finland, a study of over 56 000 first-hospitalized patients 
with up to 24-year follow-up demonstrated an increased risk of suicide caused by 
PD (Aaltonen et al. 2019). Suicide attempts have also been examined in PD. 
According to a systematic review and meta-analysis by Gournellis et al. (2018b), 
suicide attempts are more common in PD than in NPD (OR 2.11, 1.81-2.47) and the 
results also showed that the elevated risk was present in all age groups. 
2.5 Summary of the literature 
The literature review on psychotic depression shows a great deficit in knowledge 
about the etiology, risk factors, clinical characteristics and outcomes of PD. There is 
also quite a high variability in results possibly due to different study designs using 
dissimilar methodologies or subjects from incomparable age groups. The crucial 
finding is the near absence of prospective long-term follow-up studies carried out in 
naturalistic designs. Due to intermediate diagnostic stability, significant 
methodological differences between studies are the length of follow-up and the use 
of either baseline or follow-up diagnosis. Since not many studies have controlled for 
diagnostic change, most studies have used baseline diagnoses. This means that the 
PD samples included many subjects whose diagnosis would later change to for 
example SZ or BD.  
The major implication of diagnostic instability in PD on research is that studies 
should address this question, especially when analyzing the validity and utility of 
results for clinical practice. Studies should be preferably carried out in incidence 
samples and diagnostic conversion should be controlled using a sufficient follow-up 
(Heslin & Young).  Considering the clinical usefulness of research, simply 
controlling for diagnostic change is not enough because clinical decisions need to be 
made at baseline. A deeper understanding of the interplay between psychotic and 
depressive symptomatology is needed to identify beforehand those patients whose 
illness is likely to develop into other symptom constellations. 
The prevalence rate in PD is relatively high compared to other psychotic 
disorders and it is worth wondering why PD has remained so under-researched. The 
knowledge base regarding risk factors of PD is especially thin. Consistent finding 
throughout the literature review is the severe course of illness in PD that negatively 
exceeds outcomes in NPD. Mortality and suicide rates are likely to be elevated in 
PD. Previous research also indicates a clear neurobiological disturbance in PD that 
affects at least the HPA axis and related neurophysiology. To summarize, the results 
of the previous studies depict a grave disorder with unique characteristics and poor 
outcomes and emphasize the need for more prospective and representative studies to 
be carried out. 
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3 Aims 
The objective of this thesis was to study the risk factors, clinical characteristics and 
outcomes of PD. Regarding these factors, the intention was to investigate whether 
there are significant differences between PD and other severe mental disorders. 
Firstly, a systematic literature review and meta-analysis on the subject was carried 
out. Secondly, a study was conducted in a naturalistic birth cohort using lifetime 
diagnoses.  
 
The research questions were: 
Study I According to previous literature, what are the risk factors of PD and 
does PD differ from other severe mental disorders (SZ, PBD, NPD, 
PNOS) in the clinical characteristics and outcomes? 
 
Study II Are there significant early life and adolescent risk factors for PD and 
are there differences between PD and other severe mental disorders (SZ, 
PBD, NPD, PNOS) concerning these factors? 
 
Study III Are there differences between PD and other severe mental disorders 
(SZ, PBD, NPD, PNOS) in the clinical characteristics and outcomes 
based on a naturalistic birth cohort sample? 
 
Study IV Does gender or psychiatric comorbidity affect the clinical picture or 
outcome of PD and in what way? 
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4 Materials and Methods 
4.1 Meta-analysis and systematic review (Study I) 
4.1.1 Meta-analysis as a research method 
Meta-analysis refers to the statistical technique with which the results from many 
resembling studies of a certain subject can be combined (Glass 1976). The data from 
the primary studies are analyzed together to create an estimate of an effect. Also, the 
between-study heterogeneity and the impact of biases can be evaluated (Sutton & 
Higgins 2008).  
The rapid growth of published research literature and the need for fast and 
scientifically justified decisions in medicine have made meta-analyses a frequently 
applied method to synthesize knowledge from individual studies (Stroup et al. 2000). 
In the past, medical research was summarized in narrative reviews that lacked a 
systematic approach and quantitative analysis of combined data (Thacker 1988). 
These are important characteristics that form the basis of meta-analysis. 
When conducting a meta-analysis, numerous factors need to be taken into 
consideration to avoid errors that may lead to invalid or misleading results. A meta-
analysis is often an effort to retrospectively integrate studies that have been 
conducted with varying methodologies and potential biases. Therefore, meta-
analyses should address these questions in detail and, also, exclude flawed studies 
(Ioannidis 2017). A systematic assessment of primary studies is essential to achieve 
this. 
4.1.2 Data collection 
The PRISMA (Preferred Reporting Items for Systematic reviews and Meta-analyses) 
guidelines were followed in the design of the systematic review and meta-analyses 
(Moher et al. 2009).  
Relevant studies were located by conducting a systematic database search in May 
2016. Four different electronic databases were used (PubMed, Scopus, Web of 
Science and CINAHL). The used search string was as follows: (“psychotic 
depression” OR “delusional depression” OR “depression with psychotic features”) 
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AND (epidemiology OR “risk factor” OR outcome OR employment OR 
occupational OR progression OR course OR stability OR relapse OR remission OR 
prevalence OR incidence OR “onset age” OR “diagnostic stability” OR mortality 
OR mortality OR suicide OR physical OR somatic OR comorbidity OR “early 
intervention” OR prevention). There were no exclusions made based on publication 
date. In addition, reference lists of previous reviews were used to do a manual search. 
The analysis of all abstracts was made by two independent authors. Following 
the exclusion of inapplicable articles, the remaining ones were inspected by two 
authors (one of whom was the same as in the primary analysis). A third author 
extracted the data out of those articles that met inclusion criteria. After this, the 
collected data was again checked by two authors. In case of disagreement concerning 
the extraction of data, a resolution was approved by reaching consensus. 
4.1.3 Study selection 
For a study on prevalence and incidence of PD to be included, it needed to use 
estimates from population surveys or include both inpatient and outpatient data. As 
for risk factor and outcome studies, the following inclusion criteria were used: A) 
Sample of PD was included in the original study. The sample needed to include at 
least 80% of PD (delusional depressions were included). Episodes of psychotic 
depression in SZ or PBD and postpartum PD were excluded. B) The sample size of 
PD was at least 15. C) The majority of subjects had an onset age of over 16 years. 
D) The results of the studies included risk factors, sociodemographic factors or 
outcomes of PD. E) Diagnoses of PD were done using a common diagnostic system 
or otherwise properly reported. F) Studies had to include a comparison group of at 
least 15 subjects and the comparison group needed to include a minimum of 80% of 
either NPD, PBD, SZ, schizoaffective disorder or HC.  
Intervention studies were excluded due to variation in representativeness, so the 
meta-analysis only included observational studies. In addition, only studies 
published in English were included. Furthermore, studies focusing on treatment, 
neurobiology, somatic comorbidities, mortality and suicide were excluded due to 
being outside of the scope of this meta-analysis. 
4.1.4 Incidence, prevalence and risk factor studies 
A systematic review was used to report studies concerning incidence and prevalence. 
Most risk factors were also reported using a narrative approach and results were 
presented in a literature table. Risk factors in this study included both early risk 
factors and cross-sectional sociodemographic factors. A meta-analysis was able to 
be conducted on gender distribution and onset age. 
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4.1.5 Outcome studies 
The following outcome variables reported in the studies were included: the number 
of hospitalizations during prospective follow-up, occupational functioning, 
symptomatic remission, global outcome, global clinical outcome, the severity of 
psychotic symptoms (positive, negative and total symptoms were evaluated 
separately), the severity of depression symptoms. Global clinical outcome refers to 
outcomes measured without specific instruments. Global outcome refers to an 
outcome that is measured with a specific instrument such as GAF (Global 
Assessment of Functioning scale), GAS (Global Assessment Scale) or SOFAS 
(Social and Occupational Functioning Assessment Scale).  
Meta-analysis was performed on those outcomes that were reported in at least 
three studies from different samples. These included depression symptoms, total 
psychotic symptoms, positive symptoms, negative symptoms, symptomatic 
remission, hospitalization, global outcome and poor global clinical outcome. For 
symptom measurements, the most common time of assessment was the baseline, and 
this was used in the meta-analysis. PD was compared to NPD, SZ and PBD when 
there was sufficient data available. The occupational outcome was reported 
narratively. 
4.1.6 Statistical analyses 
Meta-analyses were conducted if there were a minimum of three studies 
investigating a specific variable. In case there were multiple studies with partly or 
completely same samples, the article with the largest sample size or the one using 
more valid instruments was chosen. Pooled estimates of effect sizes between PD and 
comparison groups were created using random-effects models in the meta-analyses, 
based on associations’ expected heterogeneity. Every study was weighted by the 
inverse of its variance and the between-study variance. Hedges’ g was used to 
describe the effect sizes of the between-group standardized mean differences. 
Hedges’ g is analogous to Cohen’s d but better suited for the analysis of small 
samples. Hedges’ g values above zero indicate more symptoms or later onset age in 
PD. Regarding categorical variables, Relative Risk (RR) with a 95% confidence 
interval (CI) was used to estimate pooled effect size. 
Subgroups of studies were analyzed separately when there were enough studies. 
The division into subgroups was made based on mean study age (below 45, 45-55, 
over 55 years), publication year (1973-1991, 1993-2003, 2004-2016) and mean age 
of illness onset (below 45 years, 45 years or over). Sensitivity analyses were also 
conducted based on sample size (n<50 vs. n≥50). 
The degree of heterogeneity was examined with I2 statistics in which values range 
from 0 to 100% describing the total variation of studies (Higgins et al. 2003). The 
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significance of this heterogeneity was evaluated by using the chi-square test. Metan 
command of the 13th version of Stata (Statacorp 2013) was used in all the analyses. 
4.2 The Northern Finland Birth Cohort 1966 
The Studies II-IV were conducted in the Northern Finland Birth Cohort 1966 (NFBC 
1966; https://www.oulu.fi/nfbc/), which is a general-population birth cohort study 
consisting of 12068 pregnant women and their 12058 live-born children who had an 
expected delivery date in 1966. The study takes place in the North of Finland 
covering the provinces of Lapland and Oulu. Professor Paula Rantakallio originally 
launched the study with an interest in the somatic health of infants. Later in 1990, 
Professor Matti Isohanni started psychiatric research in the NFBC 1966 focusing on 
long-term perspectives on SZ. The study design is prospective in nature and the 
sample is unselected.  
The NFBC 1966 utilizes a wide range of data collection methods including 
register-data from several national registers, questionnaires and clinical measurements. 
This birth cohort design enables long-term follow-up of study subjects starting from 
pregnancy. It also makes possible the collection of a vast quantity of biological, 
psychosocial and environmental data about potential risk factors and acquirement of 
occupational, functional and treatment-user information about outcomes. 
4.2.1 Psychiatric diagnoses and study groups 
Several data sources were used to obtain information on all psychiatric diagnoses that 
the study subjects had received during their lifetime. The Care Register for Health Care 
is a nationwide register including all somatic and psychiatric inpatient hospital 
discharges with relevant ICD-diagnosis information from 1969 (Sund 2012). 
Information concerning outpatient diagnoses in specialized care starts from 1998 and 
in primary care from 2011. In Study III Care Register for Health Care information until 
the end of 2013 was used and in Studies II and IV until the end of 2016. 
Additional information was gathered from Finnish Social Insurance Institute 
registers of those subjects with a psychotic illness that granted them a right to 
reimbursable medication. This information was available from 1974-2005. 
Prescription data for antipsychotics from 1997 and data about diagnoses leading to 
pension and sick leaves were also able to be obtained. The data was supplemented 
with diagnoses from a diagnostic validation study carried out in 1997 and a subgroup 
study performed when the NFBC 1966 cohort members were 43 years old. 
Many study subjects were diagnosed with several different psychiatric disorders 
during their lifetime according to registers. This imposes challenges to the definition 
of diagnostic groups when these groups should be observed over a long follow-up 
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period. It is especially important for PD, which is shown to have a higher diagnostic 
instability than many other disorders. The formation of these diagnostic groups may 
have a significant impact on study results. In other words, it is crucial how lifetime 
diagnosis is defined. 
A hierarchical method was used to form diagnostic groups based on the most 
severe lifetime diagnosis. All lifetime diagnoses of each subject were acknowledged 
and the diagnosis which had the highest position in the hierarchy determined the 
group (Table 2) the subject was positioned into. The hierarchy is described in Figure 
2. An exception to the hierarchy is that subjects with both PD and delusional disorder 
or both PD and non-psychotic bipolar disorder diagnoses were excluded. 
Implementation of the methods means that none of the PD group subjects had been 
diagnosed with SZ, BD or delusional disorder during their life. All PD group 
subjects' lifetime diagnoses were additionally manually checked to make sure there 
were no diagnoses that would invalidate the PD diagnosis. As previously mentioned, 
in Study III, the diagnostic information was available until the end of 2013 and in 
Studies II and IV until the end of 2016. This resulted in small differences in the PD 
sample. In Study III there were 55 PD subjects, whereas 58 subjects in Studies II and 
IV. Between the beginning of 2014 and the end of 2016, 5 new subjects were 
diagnosed with PD while two subjects exited the group due to a diagnosis of 
schizophrenia or bipolar disorder. 
Since the 1960s, the diagnostic system in Finland has changed from ICD-8 (used 
in Finland from 1968 to 1986) first to ICD-9 (from 1987-1995) and then to ICD-10 
(from 1996). To form the lifetime diagnostic groups, the diagnoses from previous 
diagnostic systems that described up-to-date diagnostic categories in the best 
possible way were selected. These diagnoses are presented in Table 2. Diagnostic 
groups of SZ, PBD, PNOS (Other Psychoses) and NPD were used as comparison 
groups for PD in Study III. In study II, HC, who did not have any lifetime psychiatric 
diagnoses, were used as a comparison, in addition to the abovementioned groups. 
Table 2.  Diagnostic categories based on ICD-8-10 used in the current study (Study III). 
 ICD-8 ICD-9 ICD-10 
PSYCHOTIC 
DEPRESSION (PD) 
2960, 2980 2961E F32.3, F33.3 
NON-PSYCHOTIC 
DEPRESSION (NPD) 
3004, 7902 2961A-D, 3004 F32.0-32.2, F32.8-
F33.2, F33.4-F33.9, 
F34.1, F38.10 
SCHIZOPHRENIA (SZ) 295, 2954, 2957 295, 2954, 2957 F20, F25 
PSYCHOTIC BIPOLAR 
DISORDER (PBD) 
2961-2969 2962E, 2963E, 2964E, 
2967 
F30.2, F31.2, F31.5 
OTHER PSYCHOSES 
(PNOS) 
297, 298 (except 
2980), 299 
297, 2988, 2989 F22, F23, F24, F28, 
F29 
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Figure 2.  Illustration of the diagnostic hierarchy. Highest diagnosis in the hierarchy during a 
subject’s lifetime defined the diagnostic category. Patients with both PD and delusional 
disorder or non-psychotic bipolar disorder were excluded from the PD group. Other 
diagnostic groups concerning Other Psychoses or higher include subjects with non-
psychotic bipolar disorder diagnosis. 
4.2.2 Early childhood and adolescent risk factors (Study II) 
In Study II the early and adolescent risk factors of PD were analyzed. First, PD was 
compared to HC, and then PD was compared to all other disorder groups. The study 
was designed, in addition to presenting risk factors of PD, to reveal the differences 
in risk factors in different disorder groups. Relevant and available potential risk 
factors from birth until the age of 16 were examined.  
4.2.2.1 Data acquisition 
Several sources were used to obtain data about potential risk factors. There was some 
variation in the amount of missing data (0-32.8%). The average proportion of 
missing data in the PD group was 9.2%. Psychiatric and somatic illness of the 
parents was examined using the same registers as with study group formation. In 
addition to mental illness in the family, parents’ somatic illness (hospitalizations ≥30 
days) was analyzed as a marker of childhood traumatic event (Keskinen et al. 2015). 
Concerning somatic illness, those hospitalizations that took place before the end of 
1982 were included, and for psychiatric illness (any psychiatric illness, psychosis, 
SZ, depression, BD and alcohol use disorder), those diagnoses that were registered 
before the study subjects turned 16. 
For psychosocial risk factors, risk factors during birth and risk factors at the age 
of 14 were separately looked into. A questionnaire (filled in 1965-1966) was used to 
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examine risk factors at birth. These included mother’s antenatal mood, 
unwantedness of pregnancy, mother’s education, urbanicity and social class in 1966 
(determined by father’s occupation) (Myhrman et al. 1996, Keskinen et al. 2013). 
Another questionnaire was filled by the study subjects at the age of 14 and the 
variables based on this were: moving hometown in 1966-1980, mother’s work status, 
family type, social class in 1980 (determined by father’s occupation) and deceased 
siblings. 
The early biological risk factors of paternal and maternal age, mother’s 
antenatal smoking, perinatal complications, birth weight, gestational age, birth 
weight/gestational age and parity were gathered from the questionnaire of 1965-66 
(Mäki et al. 2009, Keskinen et al. 2013), that was filled by a nurse at the antenatal 
clinic or birth. Motor development was observed, and parents interviewed at the 
Finnish welfare clinics routinely and this data was used to form the variables of age 
when the child learns to walk without support and age when the child learns to stand 
without support (Keskinen et al. 2015).  
Information about the school level, at which the subjects were when they were 
14 years old, was obtained from the National Board of Education and combined with 
the information from the postal questionnaire of 1980. School grades at age 16 were 
acquired from the Finnish national application system for upper secondary education 
register (Isohanni et al. 1999). 
Alcohol and smoking consumption, BMI and frequency of sport hobbies data 
came from the questionnaire that the study subjects filled in 1980. This same 
questionnaire was also used for psychosocial risk factors in adolescence, mentioned 
above. 
4.2.2.2 Statistical analyses 
Contingency tables were used to analyze different variables in all the diagnostic 
groups focusing on frequency distributions. Then PD was compared to HC using the 
Cox Proportional-Hazards model, in which the endpoint was illness onset, death, 
moving abroad or the end of 2016. Hazard Ratios were first calculated separately for 
every risk factor and after that, a multivariate Cox regression model was performed. 
Multivariate model inclusion criteria for variables were as follows: A) p-value 
(p<0.1) in the univariate analysis for minimum one category, B) in case of 
overlapping variables (parental mental illness variables, sports grade/physical 
activity), the one with the lowest p-value was picked. 
A separate analysis to compare PD risk factors to all other disorder groups was 
conducted. For this, Pearson’s Chi-Square test or Fisher’s exact test were applied. 
SPSS version 25 was used in all the statistical analyses performed in the study 
(https://www.ibm.com/analytics/spss-statistics-software). 
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4.2.3 Clinical characteristics and outcomes (Study III) 
In this Study III, the clinical course and characteristics of PD were examined. 
Information about sociodemography, educational background, onset age, 
comorbidity, mortality, hospitalization and the occupational outcome was collected. 
The time to readmission after the first hospitalization due to any psychiatric illness 
was also analyzed. Regarding these variables, a comparison to other disorder groups 
was made.  
4.2.3.1 Data acquisition 
All data concerning psychiatric diagnoses, including comorbidity and onset age, 
were obtained from national registers similarly as previously reported (4.2.1 
Psychiatric Diagnoses). Hospitalization and readmission data were acquired from 
the Care Register of Finland until the end of 2015. The occupational outcome was 
studied using registers from the Finnish Center for Pensions. Data from 2014-2015 
was applied to analyze the proportion of working days (0-100%) during that period 
and disability pension figures were available until the end of 2015. Statistics Finland 
registers until the end of 2015 were used to record the educational status of study 
subjects. Mortality was analyzed with the Population Register Center data, available 
until the end of 2015. 
4.2.3.2 Statistical analyses 
When comparing PD to other diagnostic groups, the Mann-Whitney U test was used 
for differences in median onset-ages, the median amount of hospitalizations, median 
cumulative hospitalization days and the relative proportion of hospitalization days 
from illness onset to death or end of the follow-up. For the differences in mortality, 
gender, comorbidity, the proportion of working days, disability pension rate, 
educational level and the number of subjects with at least one lifetime occurrence of 
hospitalization, Pearson’s chi-square test or Fisher’s exact test was applied. Survival 
curves, describing readmission rate after the first hospitalization due to any 
psychiatric illness, were analyzed using the log-rank test. R version 3.3.2 
(http://www.R-project.org) was applied in all statistical analyses. 
4.2.4 Effects of gender and psychiatric comorbidity on the 
outcomes (Study IV) 
Study IV was designed to analyze how gender and psychiatric comorbidity affect the 
outcome of PD. Illness onset age, lifetime hospitalization days, disability pension 
rate and mortality were examined. A comparison was made between subgroups of 
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PD based on gender and comorbid personality or alcohol use disorder. Potential 
differences between genders in the prevalence of psychiatric comorbidities 
(personality or alcohol use disorder) were also studied. 
4.2.4.1 Data acquisition 
Psychiatric diagnoses for study group formation, onset age and comorbidity were 
acquired from several sources, as reported above (4.2.1 Psychiatric Diagnoses). 
Information about the total lifetime hospitalization days for each subject was 
obtained from The Care Register for Health Care, and this data was available until 
the end of 2015. For mortality, Population Register Center data until the end of 2015 
was utilized. For disability pension rate, Statistics Finland data from 2014 was used. 
4.2.4.2 Statistical analyses 
Statistical comparisons were made on outcome variables between subgroups of PD 
(male vs. female, personality disorder vs. no personality disorder, alcohol use 
disorder vs. no alcohol use disorder). Lifetime hospitalization days and age of illness 
onset were analyzed using the Mann-Whitney U test, while for disability pension 
rate and mortality, Fisher’s exact test was applied. Additionally, the gender 
differences in comorbidity were analyzed, and for that Fisher’s exact test was used. 
SPSS version 25 was the statistical program used in all the analyses conducted in 
this study. (https://www.ibm.com/analytics/spss-statistics-software). 
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5 Results 
5.1 Meta-analysis and systematic review of 
epidemiology (Study I) 
The database search came up with 2926 records. After removing duplicates and 
excluding articles that did not fit the criteria based on title and abstract, there were 
99 articles left plus 9 articles that were manually discovered. These 108 articles were 
analyzed in the study in total and 69 of these were included in the meta-analyses. 
The summary of the results is presented in Table 3. 
5.1.1 Prevalence, incidence and proportion of psychosis in 
depression 
The prevalence and incidence were analyzed qualitatively without a meta-analysis. 
The lifetime prevalence rate varied between 0.35-1.0% in different studies 
(Supplement table 1 in Study I) and was higher among females in most studies. Point 
prevalence was reported to be 0.5% and annual incidence 0.21-6.4/100000, while 
these both were also higher among females. There were 43 studies that included PD 
and NPD patients and a median 28% of patients in these studies had PD. The 
proportion of psychotic symptoms was greater among older patients and inpatients. 
5.1.2 Risk and sociodemographic factors 
No meta-analyses were able to be conducted on the risk factors and 
sociodemographic factors of PD. Therefore, these studies (n=36, Supplement table 
4 in Study I) were analyzed narratively. Compared to NPD, PD patients more often 
had psychosis and BD in the family. Otherwise, the findings were scarce. According 
to some studies, PD patients had also more often than NPD patients experienced 
traumatic events, lived in rural surroundings and had both more acute medical 
problems and poorer social competence scores. They were also more likely to be 
non-Caucasian than NPD patients.  
Otherwise, in comparison to HC, PD patients have been noted to have more 
physical anomalies, neurological soft signs and mental illness in the family. Also, 
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PD patients more often had less contact with friends and they more often had lost a 
mother because of an unnatural cause after the age of 15, compared to HC. Only one 
study (Østergaard et al. 2013) included early life risk factors and found no significant 
differences between PD and HC. 
Table 3. Summary of essential results (Study I).  
 
Differences in gender distribution between PD and NPD were analyzed in 43 studies 
(Supplement table 2 in study I) and the meta-analysis showed no significant 
difference (RR 1.03 (0.97-1.08)). The median percentage of females was 65% in PD 
and 65% in NPD. However, a larger proportion of females was found in PD 
compared to SZ (37%; RR 1.40 (1.20-1.71)) or PBD (55%; RR 1.36 (1.01-1.83)). 
The age of the sample or the publication year did not significantly affect the gender 
distribution of PD. 
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5.1.3 Onset age 
The onset age of PD was examined in 25 studies (Supplement table 3 in Study I). No 
significant difference was found in the onset age of PD patients compared to NPD 
in the meta-analysis of 18 studies (Hedges’ g = 0.08, p=0.44). Splitting the studies 
into three categories based on subjects’ age revealed interesting results. In studies 
conducted with patients under 45 years old (n=6), PD patients had an earlier onset 
age than NPD patients (g = -0.39, p<0.001). The opposite was found in the group of 
studies of over 55 years old patients (n=7). Among these latter studies PD patients 
were found to have a later onset age (g = 0.40, p<0.001). When comparing to SZ, 
PD patients had a later onset age (5 studies, g = 0.53, p=0.013). PBD and PD did not 
have a significantly different onset age. 
5.1.4 Symptom severity, global outcome and hospitalization 
The outcome of PD was reported in 44 articles (Supplement table 5 in Study I) from 
37 different studies (sample size: n=16-190). Many of the studies (n=16) had a cross-
sectional study design and only 10 had a first-episode sample. 13 of the studies 
included a follow-up period of over 5 years.  
In comparison to NPD, PD was associated with more severe depressive (g = 0.52, 
p<0.001) and psychotic symptoms (g = 0.89, +<0.037). In other outcomes 
(symptomatic remission, hospitalization, global clinical outcome, global outcome) 
there was a trend of worse outcomes in PD, but the differences were not statistically 
significant. Sensitivity analyses (sample size) produced conflicting results. In large 
samples of 50 patients or more, the difference between depressive symptoms in PD 
and NPD was no longer significant. However, in these bigger samples, PD patients 
had less symptomatic remission and poorer clinical outcome. Some outcome 
variables between PD and NPD were only compared based on a systematic review. 
Occupational outcomes were mostly worse in PD and full recovery (symptomatic 
and functioning) more common in NPD.  
Compared to SZ, PD patients had less positive (g = -0.81, p=0.000), negative (g 
= -0.89, p<0.001) and total psychotic symptoms (g = -0.77, p=0.000), whereas there 
was no significant difference in the depressive symptom severity. According to 
meta-analysis, the global outcome of PD patients was also better than in SZ (g = 
0.80, p=0.001). The systematic review showed PD patients having a smaller rate of 
relapses, better occupational functioning and more often a full recovery. 
PD patients had more negative (g = 0.65, p=0.001) symptoms but less positive 
(g = -0.44, p=0.046) symptoms than patients with PBD. Otherwise, no difference 
was found in global functioning. The systematic review showed mostly somewhat 
similar occupational outcomes for PD and PBD. 
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Few studies had compared PD to schizoaffective disorder and no meta-analysis 
was able to be conducted. Better symptomatic remission and occupational outcomes 
have been reported in PD, but relapse rates seem to be similar (Opjordsmoen 1991). 
In one study, functional recovery was more common in PD (Tohen et al. 2000). 
5.2 Early life and adolescent risk factors (Study II) 
In this second study, the potential risk factors of PD in early life and adolescence 
were focused on. Comparison groups of NPD, SZ, PBD, PNOS and HC were used. 
There were 58 subjects with the lifetime diagnosis of PD by the end of 2016 (lifetime 
prevalence 0.5%). There was a majority of females (60.3%). The group of HC was 
the largest comparison group (n=8200). Other groups had following sizes: NPD 
(n=746), SZ (n=195), PBD (n=27), PNOS (n=136). The summary of the results of 
all analyses is presented in Figure 3. 
5.2.1 Univariate and multivariate analysis of PD risk factors 
compared to HC 
Univariate analysis of PD risk factors in comparison to HC was first performed. Any 
psychiatric illness (HR 3.63 (1.99-6.62)) and psychosis (HR 3.89 (1.41-10.73) of the 
parents were significant risk factors regarding the mental illness in the family of PD 
subjects. Affective disorders among parents did not independently increase the risk 
of PD in offspring.  
Low physical activity at age 14 (at most once a fortnight: HR 2.03 (1.00-4.12) 
increased the risk and high school sports grade in adolescence (HR 0.37 (0.16-0.82)) 
lowered the risk of PD. Also, in the univariate analysis not living in a two-parent 
household carried a higher risk for PD (HR 2.12 (1.11-4.08)). Other variables did 
not differ between PD and HC in the univariate analysis. 
A multivariate cox regression analysis was performed into which those variables 
were selected that had p<0.1 in the univariate analysis. Regarding those variable 
groups that had more than one suitable variable (parental mental illness, physical 
activity), the one with the lowest p-value was chosen. The multivariate model 
included the following variables: parent’s any psychiatric illness (either parent or 
both), family type in 1980, the grade of physical education in 1982 and unwantedness 
of pregnancy. Following the multivariate analysis, and thereby adjusting for 
covariates, there were only two significant variables: high school sports grade (HR 
0.29 (0.11-0.73)) was a protective factor and parental mental illness (HR 3.59 (1.84-
7.04)) a risk factor for PD. 
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Figure 3.  Summary of essential results of the risk factors and 
protecting factors in Psychotic Depression 
5.2.2 Comparison between PD and other disorder groups 
A comparison between PD and different disorder groups was also carried out. Most 
findings were non-significant. Parental mental illness was more common among 
parents of PD subjects compared to NPD subjects (p=0.031). PD subjects were less 
often at a lower school level than those with SZ (PD=5.4%, SZ=17.4%, p=0.031). 
Furthermore, subjects with PD more often had deceased siblings than SZ subjects 
(PD=14.6%, SZ=4.8%, p=0.032). 
5.3 Clinical characteristics and outcomes (Study 
III) 
In this study, PD was compared to other diagnostic groups (SZ, PBD, PNOS and 
NPD) regarding clinical characteristics and outcomes. The groups were formed 
based on a hierarchical lifetime diagnosis with information about the diagnoses until 
the end of 2013. There were 55 subjects in the PD group, which accounted for a 
lifetime prevalence of 0.5% in the Northern Finland Birth Cohort 1966. The 
mortality rate in the PD group was 10.9% and there were no significant differences 
between groups. There was a significantly larger proportion of females in the PD 
group compared to SZ (PD: 56.4%; SZ: 39.8%; p=0.030). The gender distribution in 
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PD resembled that of NPD (53.2%). The summary of the main results is presented 
in Figure 4. 
 
Figure 4. Summary of essential results on clinical characteristics, psychiatric comorbidity, 
occupational outcome and hospitalization in Psychotic Depression. 
5.3.1 The clinical course of PD 
The age of illness onset of the first psychotic episode and first depression episode 
were analyzed separately. PD subjects had a later onset of psychosis than those with 
SZ or PNOS (p<0.001 both) but an earlier onset of depression than those with NPD 
(p<0.05). A detailed analysis of lifetime hospitalization was also performed in all 
disorder groups. The hospitalization rate was intermediate among PD subjects. PD 
group subjects had a median of 5 lifetime hospitalization periods, which was 
significantly less than in SZ (n=8, p=0.002) but more than in NPD (n=0, p<0.001). 
Results concerning lifetime hospitalization days paralleled the hospitalization 
periods: PD was associated with more hospitalization days (n=84) than NPD (n=0, 
p<0.001) but less than in SZ (n=254, p<0.001). However, one can conclude that 
hospitalization periods were much longer in SZ on average. 
Most PD patients had been hospitalized at least once during their lifetime 
(96.4%) and this was significantly more common than in NPD (p<0.001). In the PD 
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group, the proportion of psychiatric hospitalization days from illness onset until 
death or end of follow-up was 2.07%. This was, comparably to other results, more 
than in NPD (p<0.001) and less than in SZ (p=0.004). Since the NPD group in this 
study included mild and moderate depressions in addition to severe depression, the 
lifetime hospitalization days were separately looked into for those who had been 
hospitalized at least once. There was still a clear difference between PD (n=84) and 
NPD (n=15, p<0.001). 
When comparing PD to PBD or PNOS, consistent differences were not found. 
However, the PD group was associated with more hospitalization on certain 
variables. PD subjects had more often been hospitalized at least once during their 
lifetime than PBD patients, while PNOS group subjects had less lifetime 
hospitalization periods (n=2, p=0.003) and smaller proportion of hospitalization days 
from illness onset until death or end of follow-up (0.86%, p=0.002). 
Survival curve analysis of readmissions revealed a significantly shorter time to 
rehospitalization after first lifetime psychiatric hospitalization in the PD group than 
in the NPD group (p<0.01). SZ was oppositely associated with more rapid 
rehospitalization (p<0.05). There were no significant differences between PD and 
PBD or PNOS. 
5.3.2 Comorbidity 
Psychiatric comorbidity was found to be especially common in the PD group. 
Alcohol use disorder was found in 43.6% of PD subjects and 40.0% had been 
diagnosed with a personality disorder. The prevalence of both these disorders was 
higher than in any other diagnostic group in absolute numbers. There was a 
statistically significant difference in the frequency of comorbid alcohol use disorder 
when PD was compared to SZ (p<0.001), NPD (p=0.002) and PNOS (p<0.05).  
Personality disorders were significantly more common in PD than in NPD 
(p<0.001). There were no significant differences in the prevalence of comorbid 
anxiety disorders. 
5.3.3 Educational background and occupational functioning 
The educational level was examined in different study groups. There were no 
statistically significant differences between PD and any other group. However, in 
absolute numbers, PD subjects tended to have more often a high education than SZ 
subjects (32.7% in PD vs. 18.8% in SZ). 
PD subjects were more often on a disability pension than subjects with NPD 
(p<0.001) but less often than SZ group subjects (p<0.001). Occupational functioning 
was also evaluated by analyzing the proportion of working days in the years 2013-
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2014 in different disorder groups. The purpose was to examine how actively subjects 
were participating in working life (0-100% of working days). Active participation 
(≥75%) was most common in the NPD group (44.3%), while low participation 
(≤25%) was most infrequent (40.9%).  Among PD subjects these proportions were 
24.5% and 67.3%, which implicated significantly lower participation than in NPD 
(p=0.006) but more than in the SZ group (7.8% and 90.3%, p<0.001). There were no 
significant differences between PD and PBD or PNOS in disability pension rate or 
proportion of working days. 
5.4 Effects of gender and psychiatric comorbidity 
on the outcomes (Study IV) 
The fourth study was carried out to examine the effect of gender and psychiatric 
comorbidity on the outcomes of PD. Information about lifetime psychiatric 
diagnoses until the end of 2016 were utilized and there were 58 subjects in the PD 
group, comprising of 23 males and 35 females. The mortality rate was 10.3% (n=6, 
male=4, female=2). Regarding comorbidity, alcohol use disorders and personality 
disorders were focused on, since it was previously found (Study III) that they were 
especially prevalent in PD.  
5.4.1 Gender differences in PD 
While the average onset age of PD in the whole sample was 40.2 years, there was a 
5.6 years difference in the median onset age of males and females (male: 37.3 years, 
female:42.9 years). This difference between genders was however non-significant 
statistically. When observing lifetime hospitalization days, a significant gender 
difference was found with male sex being associated with more lifetime 
hospitalization (p=0.03). The disability pension rate was similar between both 
genders. Male and female subjects were found to have different comorbidity profiles 
(Figure 6). Comorbid alcohol use disorder was more common among men (male: 
60.9%, female: 28.6%, p=0.028). Men also more often had been diagnosed with a 
personality disorder, the difference being statistically non-significant (male: 52.2%, 
female: 28.6%, p=0.098).  
5.4.2 Effect of psychiatric comorbidity on the outcomes 
Comorbid personality disorder had many negative effects on the outcome of PD 
subjects. It was associated with earlier median onset age (36.0 vs 42.4 years; p<0.01), 
more lifetime hospitalization (p<0.001) and higher mortality (p=0.03). The most 
common personality disorder diagnoses were emotionally unstable personality 
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disorder (n=7; B cluster: n=9) and unspecified personality disorder (n=7). Four 
subjects had an A cluster and two subjects a C cluster personality disorder diagnosis. 
Those who had a comorbid alcohol use disorder also had been hospitalized for a 
larger cumulative number of days (p<0.01) but other effects on the outcome were 
not statistically significant. To summarize (Figure 5), male gender, comorbid 
personality disorder and comorbid alcohol use disorder were all associated with 
increased lifetime hospitalization, while personality disorder also predicted higher 
mortality and earlier onset age. 
 
Figure 5.  Summary of associative findings of the effects of gender and psychiatric 
comorbidity on the outcome of Psychotic Depression. 
 
Figure 6. Gender variation in subgroups based on 
comorbidity. 
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6 Discussion 
6.1 Main Findings 
The systematic review and meta-analysis (Study I) revealed a lack of studies 
concerning risk factors of PD. Mental illness in the family was a risk factor for PD 
but otherwise, findings are mostly based on single studies or the results have been 
conflicting. The lifetime prevalence of PD was found to be 0.35-1.0%. The majority 
of PD patients were females and the onset age was younger than in NPD in young 
samples (under 45 years old) and older in old samples (over 55 years old). Onset age 
in PD was older than in SZ. In Study I, it was also found that PD patients have mostly 
better outcomes than in SZ, worse than in NPD and comparable to PBD.  
In the NFBC 1966, familial mental illness was found to be a risk factor and high 
school sports grade in adolescence a protective factor for PD (Study II). Parental 
mental illness was also more common among PD than NPD subjects. PD subjects 
were less often on a lower school level and more often had deceased siblings than 
SZ subjects. Concerning clinical characteristics and outcome in the NFBC 1966 
(Study III), the lifetime prevalence of PD was 0.5% (56.4% female). PD group had 
more hospitalizations and occupational deficits than NPD but less than SZ subjects. 
Psychiatric comorbidity was especially common in PD. Male gender and psychiatric 
comorbidity (alcohol use disorder and personality disorder) were associated with 
poor outcomes (Study IV). 
6.2 Comparison to earlier studies 
The results of the original study in the NFBC 1966 were quite much in line with the 
systematic review and meta-analysis presented in this thesis. In the NFBC 1966 the 
lifetime prevalence rate of PD was 0.5%, which was similar then the results of Study 
I that found lifetime prevalence in the previous studies to be 0.35-1.00%. Gender 
distribution in the cohort was similar to the meta-analysis: females formed a majority 
comparably to NPD but oppositely to SZ.  
The finding in the NFBC 1966 of familial mental illness, especially psychosis, 
among the parents of PD subjects was in line with previous studies (Heslin et al. 
2016b). In the study, a high school sports grade at the age of 16 acted as a protective 
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factor against PD. This is a novel finding in the case of PD, but physical activity is 
known to prevent the development of depression (Schuch et al. 2018) and low 
physical activity in adolescence is likely to increase the risk of non-affective 
psychosis in adulthood (Sormunen et al. 2017). The lack of significant early risk 
factors for PD was in line with the only other prospective study about early risk 
factors in PD by Østergaard et al. (2013), in which no significant risk factors were 
also found. 
The onset age of psychosis and depression were analyzed separately in this birth 
cohort sample which made it harder to compare to previous studies. However, 
because a hierarchical lifetime diagnosis was used to form the study groups, it was 
more informative to examine the onset of psychosis and depression differently. SZ 
subjects were found to have an earlier onset age of psychosis than PD subjects and 
the onset age of depression was later for those with NPD when compared to PD. In 
the meta-analysis, PD was associated with a later onset age than SZ. Compared to 
NPD, the meta-analysis showed an age-dependent association in onset age: in young 
samples, PD patients’ onset age was earlier but in old samples later than in NPD. 
Since the NFBC 1966 sample represents a young sample, the results concerning 
onset age were in line with the previous studies. 
The high proportion of PD among all depressive patients (28%), discovered in 
our meta-analysis, is likely to reflect the severe symptom profiles within the sample 
populations. When only those studies, that included both in- and outpatients or only 
outpatients, were included, the proportion of PD was 19%. Even this number seems 
to be very high when comparing the lifetime prevalence rates of PD and NPD. One 
explanation is the use of mostly secondary care data in these studies: psychotic 
symptoms are more common in depression when investigating secondary care 
patients compared to primary care settings (Vuorilehto et al. 2007). Furthermore, a 
disproportionately large part of NPD patients in previous studies had been 
hospitalized, compared to epidemiological samples, which needs to be considered 
when interpreting the comparison between PD and NPD. 
PD subjects had a better outcome than SZ subjects in the NFBC 1966 but worse 
than those with NPD. These differences were seen in the lifetime hospitalization rate, 
time to readmission after the first hospitalization and in the occupational outcome. 
These differences, that reflect the intermediate outcome of PD between NPD and 
SZ, are also seen in the meta-analysis. Two recent studies, published after the 
systematic search was conducted for the meta-analysis, with representative samples 
and 6-10-year follow-ups, reported similar results in the outcome of PD compared 
to SZ (Heslin et al. 2016a; Kingston et al. 2018) but did not include an NPD 
comparison group. A study by Coryell et al. (1996) with a 10-year follow-up did, 
similarly to our study, found worse outcomes in PD than in NPD. Another study in 
Germany did not find significant differences between PD and NPD in symptoms or 
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occupational functioning 15 years after the index episode (Jäger et al. 2005). In this 
study, PD was associated with more hospitalizations. The study included only 
patients who were hospitalized during the index episode, which may partly explain 
the results. Furthermore, an Italian study (Maj et al. 1990) with a 7-year follow-up 
was unable to show differences between PD and NPD, but in this study, all PD 
patients had mood-congruent symptoms, which is likely to affect the outcome of the 
sample. The systematic review and meta-analysis found also contradicting results 
regarding hospitalization and occupational outcome of PD compared to NPD, 
although the outcome in PD was generally poorer. Therefore, this study in the NFBC 
1966 is an important contribution to this insufficient evidence base and shows PD to 
have a poorer prognosis. 
Comparison analyses between PD and PBD or PNOS group in the NFBC 1966 
sample did not show quite so uniform results as with NPD and SZ. In the NFBC 
1966, there were still implications of a worse outcome in PD: PD was associated 
with more lifetime hospital days than the PNOS group. Also, there were fewer 
subjects without any hospitalizations in the PD than in the PBD group. Comparably 
to NFBC 1966, in the meta-analysis PD and PBD had comparable outcomes despite 
some differences in symptom profiles (more negative and less positive symptoms in 
PD). In the previous study most resemblant of our study design by Heslin et al. 
(2016a), PD and PBD also had mostly comparable results but PBD more often had 
an episodic course. Furthermore, a recent study, conducted in rural Ireland as part of 
the Cavan-Monaghan First Episode Psychosis Study, found no differences between 
PD and PBD at 6-year follow-up in the severity of symptoms or functional 
impairment (Kingston et al. 2018). 
The mortality rate in PD (n=6, 10.3-10.9%) in the NFBC 1966 sample was not 
significantly different than in other disorder groups, which may have been due to a 
relatively small sample. In Study I mortality was not investigated but high mortality 
has previously been reported (Vythilingam et al. 2003).  
In the NFBC 1966 sample, it is shown that male gender is associated with a 
poorer outcome and more comorbidity in PD. Gender differences in PD have not 
been extensively studied in the past. Only one previous study analyzed the effect of 
gender on the outcome of PD (Deligiannidis et al. 2013) and found no difference 
between genders in a 12-week pharmacotherapy trial. Our findings of poorer 
outcomes in the long term among males in PD are an important new result. 
As for comorbidity, in the NFBC 1966 sample, alcohol use disorder and 
personality disorder were found to be more common in PD than in other groups. The 
meta-analysis did not focus on this issue, but previous studies have shown high levels 
of substance use disorders (Tohen et al. 2012) and personality disorders (Gaudiano 
et al. 2009) in PD. This was still the first study to do a comparison to many other 
disorder groups. Also, more B cluster personality disorders were found, oppositely 
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to a finding of more A cluster personality disorders in previous studies (Serretti et 
al. 1999, Gaudiano et al. 2009), which may result from the register study design (See 
Strengths and limitations). Alcohol use disorder was more common among males in 
PD which has also been found in previous studies (Fennig et al. 1993, Isometsä et 
al. 1994). 
Psychiatric comorbidities (alcohol use and personality disorder) were associated 
with poor outcome in PD in the NFBC 1966. Especially comorbid personality 
disorder was associated with higher mortality, earlier onset age and more lifetime 
hospitalization. Personality disorders are known to be associated with poorer 
outcomes in depression (Kampman et al. 2013) and this seems to apply to PD. It is 
interesting that only two subjects had a C cluster personality disorder, which has also 
been associated with poor outcomes in depression previously (Viinamäki et al. 
2003). 
It is also noteworthy that all the deceased subjects had either comorbid alcohol 
use or personality disorder. Personality disorders are known to be a significant risk 
factor for suicide (Schneider et al. 2006), which may explain the elevated mortality 
rate. In this study, the causes of death were not analyzed. Potential reasons for higher 
mortality among those with alcohol use disorder include the effects of alcohol use 
on nutrition, physical activity and somatic health in general. Comorbid alcohol 
dependence is also a risk factor for suicide (Aaltonen et al. 2019). It is possible that 
treatment adherence in the comorbid groups has also been lower causing longer 
periods of severe symptoms that may have had an impact on physical health as well. 
Alcohol use disorders have been found to be more common among males 
previously (Addington et al. 2007) and they are likely to contribute to poorer 
outcomes in psychotic illness (Cetty et al. 2019). Mood may be more strongly 
affected by alcohol compared to other symptoms (Barrowclough et al. 2014), and 
therefore alcohol use disorder is likely to associate more strongly with PD than with 
other psychotic disorders. It is also possible that mechanisms involved in depression 
are different among those with a comorbid alcohol use disorder (Paavonen et al. 
2016). 
To summarize, this thesis demonstrated that PD is not typically a one-episode 
illness but associated with several hospitalizations, grave symptoms, functional 
impairment and high psychiatric comorbidity. Sociodemographic characteristics 
such as gender (a female majority in PD) and onset age were also analyzed for the 
first time with meta-analytical methods. The understanding of subgroup differences 
within PD was also significantly increased by the evidence that male gender and 
psychiatric comorbidity are associated with poor outcomes. The small number of 
significant risk factors and internal heterogeneity indicate that multiple different 
etiologies may be present in PD, comparably to NPD. 
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6.3 Psychotic depression on the spectrum of 
mental disorders 
Due to the dimensional nature of psychiatric illness, discussion on whether PD is a 
severe form of depression or a separate illness may be a relic from the past. The 
results of this thesis still emphasize the need to take a different stance on PD and 
NPD. PD resembles more other affective psychotic illness than NPD and is similarly 
a long-term psychotic illness than PBD. This can be seen in the number of 
hospitalizations and in the occupational outcome. 
There were only a few significant risk factors of PD in the NFBC 1966 sample 
and no major differences in risk factor profiles between PD and other disorders. 
There may be many factors explaining this finding. First, depression is known to be 
a heterogeneous entity (Lieblich et al. 2015) and many different etiologies are 
present. Secondly, it is likely that affective and non-affective psychoses do not have 
completely distinct etiological factors (Craddock & Owen 2010).  
When reflecting on the results of the whole study, the differences and similarities 
between PD and SZ depict an intriguing relationship between these two. As reported 
in the literature review, PD is associated with similar cognitive disturbances than SZ, 
in which cognitive problems are regarded as the core feature of illness (Green et al. 
2019). Also, depressive symptoms are often present in SZ (Upthegrove et al. 2017) 
likely causing negative outcomes in the long term (Conley et al. 2007). Meanwhile, 
PD is associated with later onset age and better outcomes than SZ. In addition, 
opposite to SZ, PD has a female majority. Despite many similarities, it is clear, that 
PD represents a different illness profile than SZ. Furthermore, complicating the 
picture of co-existing depressive and psychotic symptoms, depressive symptoms 
during a first-episode psychosis have negative implications for at least short-term 
outcomes (Challis et al. 2013, Gardsjord et al. 2016).  
Comparably to psychosis, depression is also a dimensional illness, and different 
patients have significant variation in the severity and number of symptoms. 
Historically, depression has been defined differently, and it is possible that certain 
important symptoms or signs are missed using only the current diagnostic criteria 
(Kendler 2016). Therefore, it is important to also look outside the diagnostic criteria 
of depression to understand how psychosis and depression are interconnected.  
In order to improve the understanding of the place of PD on the psychosis 
spectrum, prospective long-term follow-up studies, including the whole scale of 
psychotic illness, should be conducted. Furthermore, efforts to predict the course of 
illness in first-episode psychosis (Suvisaari et al. 2018) are important, since 
psychosis and depression are a common symptom combination during the first 
episode, but the diagnosis often changes during follow-up. 
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6.4 Strengths and limitations of the studies 
6.4.1 Meta-analysis and systematic review 
The study and the accompanying data search were conducted in a systematic and 
comprehensive way, which is a major strength. Some areas of research (gender, onset 
age, certain areas of outcome) were also rather well represented in the literature and 
made possible the use of integrative quantitative analysis. 
A significant limitation was the small number of original studies and the varying 
methodologies used in these studies. This applies especially to prevalence and 
incidence and resulted in the difficulty to make precise estimates. Also, the samples 
of the studies were relatively small and mostly did not focus on first-episode 
samples. In outcome studies, the used measurement methods were not completely 
homogenous. 
Because of the abovementioned scarcity of studies regarding most studied 
variables, it was not possible to make an extensive analysis of the quality of original 
studies and base exclusion on these potential flaws. However, this can be considered 
a limitation of the study. 
Another limitation is that childhood-onset samples were not included. In 
addition, it is possible that some studies have been missed due to changing 
terminology. For example, different names have been used to describe PD in the 
past. This concerns particularly older articles. The likelihood of this was minimized 
by selecting many search terms. In addition, a manual search was also conducted to 
minimize the effect of this problem.  
6.4.2 The Northern Finland Birth Cohort 1966 
The original study was conducted in the Northern Finland Birth Cohort 1966, where 
most of the diagnostic information was gathered from different national registers. 
Therefore, one clear limitation in this study was the lack of clinical diagnoses using 
validated instruments. However, the Care Register for Health Care, the primary 
source of diagnoses in the study, has been extensively used and studied in the past 
(Sund 2012). 
Related to the former is the limitation concerning the use of changing diagnostic 
systems (ICD-8-10). In the ICD-8 and ICD-9, PD is not as unquestionably defined 
as it is in ICD-10. Into the PD group were chosen those diagnoses that included non-
organic psychotic symptoms accompanied by significant depressive symptoms when 
there was not another disorder present. Also, possible changes in diagnostic practices 
(Korkeila et al. 1998) over the years cause a potential limitation. The significance of 
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these limitations is reduced by the use of hierarchical lifetime diagnoses using 
nationwide registers of psychiatric diagnoses.  
However, it is known that the diagnoses of schizophrenia (Kampman et al. 2004) 
and bipolar disorder (Fritz et al. 2017) are delayed in clinical practice and the 
diagnostic validity of the PD group could potentially be reduced by this. The age of 
the sample (50 years at the end of follow-up) can be seen to minimize this risk but 
this limitation cannot be completely excluded.  
In this study, we were not able to obtain information about those patients who 
never received treatment for their mental disorders. Since a significant proportion of 
patients with even severe depression do not seek treatment (Hämäläinen et al. 2004), 
this limitation needs to be considered when interpreting the results of this study. Due 
to a considerable number of untreated depression patients in the general population 
and the differences in patient profiles between primary and secondary care, studies 
focusing mostly on secondary care are likely not to reflect the complexity of the 
phenomena at a population level. 
Also, the age of the NFBC 1966 sample means that this original study does not 
tell anything about late-onset PD but only about those PD subjects whose illness 
began latest in 2016. This is an important limitation given that PD is common in 
older samples as well (Kivelä & Pahkala 1989). 
Another applicable concept compared to lifetime prevalence, which was mostly 
used in the study, would be cumulative incidence. Lifetime prevalence is often 
measured from a cross-sectional sample, in which the deceased subjects are missing. 
This limitation was able to be avoided because of the cohort study design, and it 
should be considered a significant strength. 
Unfortunately, data about specialist outpatient diagnoses were able to be 
obtained starting as late as from 1998 when NFBC 1966 participants were over 30 
years old. In the PD group, most (96.4%) subjects had been hospitalized, and it is 
unlikely that there would have been many PD patients who were treated only in 
outpatient care before 1998, although this is a possibility that cannot be completely 
excluded. However, since there has been a decrease in the number of psychiatric 
hospital beds and an increase in outpatient care after the 1980s and 1990s 
(Salokangas & Saarinen 1998), it would have been more likely for PD subjects to 
have been treated in outpatient care after 1998. Therefore, this lack of data should 
not be considered to be a major limitation to the validity of the PD group. 
Nevertheless, lack of outpatient data prior to 1998 reduces the validity of the 
NPD group especially, because NPD is often treated in outpatient care. However, 
this bias in the NPD group is not likely to invalidate the results of group comparisons 
between PD and NPD because the potential subjects with NPD, that were not able to 
be detected, had never been hospitalized or treated in outpatient care after 1998. This 
means that they represent a part of NPD that has a very benign course. Oppositely, 
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the sample of NPD is biased to include those with a more severe outcome. Given 
that several important differences in outcome between PD and NPD were still able 
to be detected, this potential bias emphasizes the meaning of psychotic symptoms 
for the outcome of depression. As for risk factors, since many differences were not 
found when comparing to HC, it is unlikely that a less ill sample of NPD would have 
produced more group differences between PD and NPD.  
The NPD group included diagnoses of also mild and moderate depressions, 
which can be seen to partly explain the differences observed in outcomes between 
PD and NPD groups. However, primary health care diagnostic information was 
available only from 2011, so most subjects had been treated in psychiatric clinics or 
hospitals. Also, as mentioned above, outpatient diagnoses were not available prior 
to 1998. Therefore, the NPD group comprises of subjects with significant symptoms 
and need for treatment. 
Otherwise, concerning risk factors, early life and adolescent risk factors were 
only studied, whereas many factors later in life can function to increase the risk of 
PD. Also, data about potential risk factors such as cannabis use, migration or 
childhood traumas were not available. In addition, the PD sample size was not very 
large (n=58) to detect potentially smaller effects on the risk of PD. PBD group (n=27) 
was even smaller. Still, PD group size is considered large enough for analysis and 
PBD was important to be analyzed alongside it. Considering the results, since 
multiple different risk factors were studied and a big number of group comparisons 
were made, it is still possible that certain risk factors or between-group differences 
were significant due to chance. Especially the results of low school sports grades in 
adolescence should be considered preliminary. 
No variable modification was carried out, and therefore the risk factors are 
comparable to previous studies conducted in the NFBC 1966, which is a considerable 
strength. However, it is possible that certain risk factors could have been significant 
if, for example, continuous variables would have been analyzed categorically. 
As for mental illness among parents, BD or depression were not found to be more 
common in the families of PD subjects than HC, which is more likely to be explained 
by changing diagnostic practices (Korkeila et al. 1998, Filatova et al. 2017), than by 
the real absence of these disorders. 
Outcome results in the different disorder groups were not adjusted for the 
duration of illness. However, this should not be considered a major limitation since 
the proportion of psychiatric hospital days from illness unset until death or end of 
follow-up was also analyzed, which did take illness onset into account. Results in 
this variable were comparable to other hospitalization variables. Also, all study 
participants were from the same age group and different disorders were studied in a 
naturalistic setting at the same points in life. 
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In this study, it was not possible to use data about specific treatments and 
rehabilitation that study subjects had received in the hospital or outpatient care. This 
would have been especially interesting regarding the outcomes because most studies 
about the treatment of PD have focused on the acute phase of the illness. Also, lack 
of this information means that PD outcomes in comparison to other disorder groups 
may have been partly explained by suboptimal or oppositely beneficial treatment 
practices in PD. 
Regarding the effects of psychiatric comorbidity and gender on the outcomes, 
adjusting for potential confounding factors was not done due to the explorative study 
design. Therefore, the associative findings of worse outcomes among males and 
those with psychiatric comorbidities should not be considered causal. It is also 
possible that those PD subjects who had a worse prognosis received more comorbid 
diagnoses due to more contact with health care professionals. However, the threshold 
for diagnosing alcohol use and personality disorders is often high reducing the 
likelihood of this scenario. Furthermore, register data may underestimate the 
prevalence of comorbid personality disorders. Recently, it was reported in a Finnish 
study, that 47% of patients contacting psychiatric services for the first time fulfilled 
the criteria for a personality disorder (Karukivi et al. 2017). 
6.5 Clinical implications 
In everyday clinical practice, PD is often found to be a controversial disorder with 
foggy boundaries between it and other disorders. This is also affected by the 
insufficient evidence base guiding clinical decision-making. This has negative 
consequences for those suffering from this disorder. The blurry distinction between 
diagnostic entities is present in all psychiatry due to symptom-based descriptive 
nosology, and the sidelining of PD is not entitled from this perspective either.   
Depression is a highly prevalent mental health problem in the world causing not 
only vast amounts of suffering but also significant costs for societies (Cuijpers et al. 
2012). The results of this thesis emphasize that it is very important to assess the 
presence of potential psychotic symptoms in patients with depression since they have 
significant consequences for the clinical picture, treatment and outcomes. 
Furthermore, in this thesis, the lifetime prevalence rate of PD was found to be 0.35-
1.0%, which means that PD is a rather common diagnosis in the clinic. 
The findings of this dissertation that the majority of PD patients are females and 
that onset age in PD is likely to be younger than in NPD in patients under 45 years 
old but higher in patients over 55 years old,  are important information for the 
evaluating clinician. All mental health professionals should also be aware that PD is 
associated with a more grave illness course than NPD.  
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Due to a scarcity of specific risk factors, possibilities to prevent PD remain 
uncertain. However, familial mental illness was found to be a significant risk factor 
for PD. This almost fourfold risk is important to keep in mind when evaluating and 
treating patients with depression, since psychotic symptoms may be concealed or 
otherwise hard to distinguish. Low sports grade at the age of 16 was also a significant 
risk factor in the NFBC 1966, which encourages investment in the physical activity 
of children. 
When comparing to BD, a common invalid preconception in the clinic is that PD 
is more of a single-episode disorder with a good prognosis after remission, while BD 
lasts for a lifetime and needs to be handled accordingly. However, according to the 
results of this thesis, PD carries a similar, if not worse, prognosis than PBD. 
Therefore, the necessary action should be taken to ensure PD patients' treatment is 
planned with a focus also on the long-term outcome, in addition to acute-phase 
treatment. This conclusion is something that already Kraepelin would have agreed 
to since he recognized PD and PBD to be part of the same entity. Outcomes in PD 
seem to be better than in SZ, while previous findings show a similar cognitive 
disturbance in both disorders. PD should be considered an important differential 
diagnosis in first-episode psychosis, while it also has important repercussions for 
treatment.  
The findings of the effects of gender and psychiatric comorbidity on the outcome 
showed that male gender, personality disorder and alcohol use disorder were 
associated with a more malign course in the long term. Personality disorders and 
alcohol use disorders were also especially common in PD. These results encourage 
clinicians to actively screen for comorbidities and initiate treatment for those 
disorders. 
Currently, PD patients are likely to have a greater risk of suboptimal treatment 
than SZ and BD patients due to a lack of research. This is even more probable to 
happen in an overloaded public healthcare system that emphasizes the use of only 
evidence-based treatments. Hopefully, the findings of this thesis encourage 
clinicians to carefully plan and actively implement treatments for this patient group.  
6.6 Implications for future research 
The findings of this thesis encourage future studies to focus on PD, which has proven 
to be a common disorder with severe symptoms, high comorbidity, recurring 
hospitalizations and functional impairment. Special attention should be given to 
diagnostic instability and internal heterogeneity within the PD population. In order 
for studies on PD to be clinically useful, they should include naturalistic first-episode 
samples with a long follow-up. Different subgroups of PD have large variation in 
outcomes, as shown in this thesis, and it is likely that different treatment options 
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would prove most beneficial in the subgroups. Furthermore, a more detailed analysis 
of patient characteristics (including, for example, different profiles of psychotic and 
depressive symptoms) is important in the future. One possibility is to use 
dimensional models to investigate PD. Long-term follow-up studies utilizing data 
from multiple biological, psychological, functional and symptom dimensions, in 
addition to clinical characteristics and treatments, would have much to give to the 
understanding of PD. Inclusion into these studies should not be based on diagnostic 
criteria since individual symptom profiles change so much over time, but diagnostic 
groups should still be analyzed and their validity re-evaluated. Finally, it is crucial 
to explore new options to improve the long-term outcomes of PD. Effective 
treatments in the acute phase of PD already exist but very little is known about the 
long-term outcomes of different treatment options. 
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7 Conclusions 
The research conducted on PD in the past is low in quantity and heterogeneous in 
methodology. Intermediate diagnostic stability further complicates the 
understanding of PD. However, both the systematic analysis of previous literature 
and naturalistic birth cohort study revealed a severe course of illness in PD. Several 
prognostic and symptomatic factors differentiate PD from SZ and NPD, positing it 
in between these two disorders. Clinical course in PD resembles that in PBD, which 
implicates that functional impairment is common and multiple recurring 
hospitalizations often take place. A combination of biological and cognitive changes 
is often present in PD, but few specific risk factors were found in this study. PD is 
characterized by a female majority similarly as in NPD, and male gender possibly 
indicates a more malign course of illness, as do psychiatric comorbidities, that are 
common in PD. For the clinician, these findings mean that PD needs to be treated 
with a long-term focus, while actively paying attention to comorbidities and 
acknowledging the heterogeneity of clinical pictures and outcome. To summarize 
research implications, major clinical significance and a severe scarcity of past 
research efforts underline the need for more prospective studies with a long follow-
up on PD. 
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